Dendrimers—revolutionary drugs for infectious diseases
Identifieur interne : 001183 ( Istex/Corpus ); précédent : 001182; suivant : 001184Dendrimers—revolutionary drugs for infectious diseases
Auteurs : Joanna Lazniewska ; Katarzyna Milowska ; Teresa GabryelakSource :
- Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology [ 1939-5116 ] ; 2012-09.
Abstract
Over recent years innovative nanomolecules in a form of dendrimers have been gaining increasing interest. These compounds can be designed and modified in many ways giving a molecule which meets required expectations. For this reason dendrimers are the object of intensive studies in many fields of nanoscience including one of the most thriving—biomedicine. Numerous studies provide evidence that some dendrimers exhibit activities against many species/strains of viruses, bacteria, fungi, and prions. These types of dendritic nanostructures which are distinguished by antipathogenic properties and low cytotoxicity to eukaryotic cells may be potentially applied in medicine as novel drugs for various infectious diseases, especially those which are persistent, marked by high mortality rate, or untreatable. Dendrimers can exert their effect via different mechanisms of action, which are, in most cases, related to multivalency of the nanomolecule. The application of dendrimers is likely to be a breakthrough in prevention and treatment of infectious diseases which still beset humanity and may significantly improve the quality of people's life. WIREs Nanomed Nanobiotechnol 2012, 4:469–491. doi: 10.1002/wnan.1181 For further resources related to this article, please visit the WIREs website.
Url:
DOI: 10.1002/wnan.1181
Links to Exploration step
ISTEX:9831976E5B4267DD17E6ED28BFECEFD141B6FED3Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Dendrimers—revolutionary drugs for infectious diseases</title><author><name sortKey="Lazniewska, Joanna" sort="Lazniewska, Joanna" uniqKey="Lazniewska J" first="Joanna" last="Lazniewska">Joanna Lazniewska</name><affiliation><mods:affiliation>Department of General Biophysics, University of Lodz, Lodz, Poland</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: joanna.lazn@gmail.com</mods:affiliation></affiliation><affiliation><mods:affiliation>Correspondence address: Department of General Biophysics, University of Lodz, Lodz, Poland</mods:affiliation></affiliation></author><author><name sortKey="Milowska, Katarzyna" sort="Milowska, Katarzyna" uniqKey="Milowska K" first="Katarzyna" last="Milowska">Katarzyna Milowska</name><affiliation><mods:affiliation>Department of General Biophysics, University of Lodz, Lodz, Poland</mods:affiliation></affiliation></author><author><name sortKey="Gabryelak, Teresa" sort="Gabryelak, Teresa" uniqKey="Gabryelak T" first="Teresa" last="Gabryelak">Teresa Gabryelak</name><affiliation><mods:affiliation>Department of General Biophysics, University of Lodz, Lodz, Poland</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:9831976E5B4267DD17E6ED28BFECEFD141B6FED3</idno><date when="2012" year="2012">2012</date><idno type="doi">10.1002/wnan.1181</idno><idno type="url">https://api.istex.fr/ark:/67375/WNG-GGNMRLN8-Z/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">001183</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001183</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">Dendrimers—revolutionary drugs for infectious diseases</title><author><name sortKey="Lazniewska, Joanna" sort="Lazniewska, Joanna" uniqKey="Lazniewska J" first="Joanna" last="Lazniewska">Joanna Lazniewska</name><affiliation><mods:affiliation>Department of General Biophysics, University of Lodz, Lodz, Poland</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: joanna.lazn@gmail.com</mods:affiliation></affiliation><affiliation><mods:affiliation>Correspondence address: Department of General Biophysics, University of Lodz, Lodz, Poland</mods:affiliation></affiliation></author><author><name sortKey="Milowska, Katarzyna" sort="Milowska, Katarzyna" uniqKey="Milowska K" first="Katarzyna" last="Milowska">Katarzyna Milowska</name><affiliation><mods:affiliation>Department of General Biophysics, University of Lodz, Lodz, Poland</mods:affiliation></affiliation></author><author><name sortKey="Gabryelak, Teresa" sort="Gabryelak, Teresa" uniqKey="Gabryelak T" first="Teresa" last="Gabryelak">Teresa Gabryelak</name><affiliation><mods:affiliation>Department of General Biophysics, University of Lodz, Lodz, Poland</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology</title><title level="j" type="alt">WILEY INTERDISCIPLINARY REVIEWS: NANOMEDICINE AND NANOBIOTECHNOLOGY</title><idno type="ISSN">1939-5116</idno><idno type="eISSN">1939-0041</idno><imprint><biblScope unit="vol">4</biblScope><biblScope unit="issue">5</biblScope><biblScope unit="page" from="469">469</biblScope><biblScope unit="page" to="491">491</biblScope><biblScope unit="page-count">23</biblScope><publisher>John Wiley & Sons, Inc.</publisher><pubPlace>Hoboken, USA</pubPlace><date type="published" when="2012-09">2012-09</date></imprint><idno type="ISSN">1939-5116</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1939-5116</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Over recent years innovative nanomolecules in a form of dendrimers have been gaining increasing interest. These compounds can be designed and modified in many ways giving a molecule which meets required expectations. For this reason dendrimers are the object of intensive studies in many fields of nanoscience including one of the most thriving—biomedicine. Numerous studies provide evidence that some dendrimers exhibit activities against many species/strains of viruses, bacteria, fungi, and prions. These types of dendritic nanostructures which are distinguished by antipathogenic properties and low cytotoxicity to eukaryotic cells may be potentially applied in medicine as novel drugs for various infectious diseases, especially those which are persistent, marked by high mortality rate, or untreatable. Dendrimers can exert their effect via different mechanisms of action, which are, in most cases, related to multivalency of the nanomolecule. The application of dendrimers is likely to be a breakthrough in prevention and treatment of infectious diseases which still beset humanity and may significantly improve the quality of people's life. WIREs Nanomed Nanobiotechnol 2012, 4:469–491. doi: 10.1002/wnan.1181 For further resources related to this article, please visit the WIREs website.</div></front></TEI><istex><corpusName>wiley</corpusName><keywords><teeft><json:string>dendrimers</json:string><json:string>dendrimer</json:string><json:string>pamam</json:string><json:string>viral</json:string><json:string>chem</json:string><json:string>dendritic</json:string><json:string>carbosilane</json:string><json:string>wiley periodical</json:string><json:string>coli</json:string><json:string>peptide</json:string><json:string>receptor</json:string><json:string>antibacterial</json:string><json:string>antimicrobial</json:string><json:string>aeruginosa</json:string><json:string>moiety</json:string><json:string>aureus</json:string><json:string>majoral</json:string><json:string>antiviral</json:string><json:string>herpes</json:string><json:string>overview</json:string><json:string>nanomedicine</json:string><json:string>toxicity</json:string><json:string>nanobiotechnology</json:string><json:string>ebola</json:string><json:string>caminade</json:string><json:string>hcmv</json:string><json:string>carbosilane dendrimers</json:string><json:string>nanobiotechnology drug</json:string><json:string>permeability</json:string><json:string>cationic</json:string><json:string>cytotoxicity</json:string><json:string>wire nanomedicine</json:string><json:string>infectious disease</json:string><json:string>lysine</json:string><json:string>solubility</json:string><json:string>lectin</json:string><json:string>biol</json:string><json:string>antifungal</json:string><json:string>sialic</json:string><json:string>biofilms</json:string><json:string>alkyl</json:string><json:string>antipathogenic</json:string><json:string>bryszewska</json:string><json:string>polymer</json:string><json:string>cell line</json:string><json:string>microbiol</json:string><json:string>membrane permeability</json:string><json:string>polyamidoamine</json:string><json:string>persister</json:string><json:string>bioorg</json:string><json:string>cytomegalovirus</json:string><json:string>faecalis</json:string><json:string>biomedical</json:string><json:string>pamam dendrimers</json:string><json:string>dendrimeric</json:string><json:string>pathogen</json:string><json:string>polym</json:string><json:string>galcer</json:string><json:string>dendritic polymer</json:string><json:string>bacterial membrane</json:string><json:string>alkyl chain</json:string><json:string>peptide dendrimers</json:string><json:string>chemical structure</json:string><json:string>vaccine</json:string><json:string>simplex</json:string><json:string>phosphorus</json:string><json:string>herpes simplex virus</json:string><json:string>antimicrob agent chemother</json:string><json:string>antipathogenic property</json:string><json:string>higher concentration</json:string><json:string>potent inhibitor</json:string><json:string>target cell</json:string><json:string>cell disruption</json:string><json:string>cell membrane</json:string><json:string>fungal</json:string><json:string>influenza</json:string><json:string>replication</json:string><json:string>viral particle</json:string><json:string>human cytomegalovirus</json:string><json:string>viral envelope</json:string><json:string>functional group</json:string><json:string>high affinity</json:string><json:string>cationic aminoacids</json:string><json:string>inhibitory potential</json:string><json:string>antibacterial activity</json:string><json:string>broad spectrum</json:string><json:string>multivalent</json:string><json:string>inhibitory</json:string><json:string>inhibitor</json:string><json:string>derivative</json:string><json:string>suzuki</json:string><json:string>infection</json:string><json:string>medical application</json:string><json:string>nanomed nanotech biol</json:string><json:string>research group</json:string><json:string>good candidate</json:string><json:string>broad range</json:string><json:string>pseudomonas aeruginosa</json:string><json:string>enterococcus faecalis</json:string><json:string>host cell</json:string><json:string>dendritic cell</json:string><json:string>biol chem</json:string><json:string>late stage</json:string><json:string>phosphorus dendrimers</json:string><json:string>monosodium salt compound</json:string><json:string>cell culture</json:string><json:string>potential application</json:string><json:string>molecular weight</json:string><json:string>antimicrobial activity</json:string><json:string>peptide dendrimer</json:string><json:string>further study</json:string><json:string>antifungal activity</json:string><json:string>persister cell</json:string><json:string>drug deliv</json:string><json:string>prog polym</json:string><json:string>cancer cell</json:string><json:string>chem lett</json:string><json:string>periodical</json:string><json:string>membrane</json:string><json:string>infection process</json:string><json:string>convergent method</json:string><json:string>primaquine phosphate</json:string><json:string>different number</json:string><json:string>host cell receptor</json:string><json:string>bacterial infection</json:string><json:string>hydrogen bond</json:string><json:string>hcec cell line</json:string><json:string>electrostatic interaction</json:string><json:string>simultaneous binding</json:string><json:string>cell wall</json:string><json:string>thioglycoside moiety</json:string><json:string>host cell dendrimers block receptor</json:string><json:string>multivalent agent</json:string><json:string>inhibitory effect</json:string><json:string>hemorrhagic fever</json:string><json:string>high mortality rate</json:string><json:string>viral replication</json:string><json:string>high importance</json:string><json:string>antimicrobial peptide</json:string><json:string>trans infection</json:string><json:string>exhibit inhibitory effect</json:string><json:string>more resistant</json:string><json:string>proteus vulgaris</json:string><json:string>effective vaccine</json:string><json:string>thiourea linkage</json:string><json:string>susceptible cell</json:string><json:string>micrococcus luteus</json:string><json:string>virus entry</json:string><json:string>virus replication</json:string><json:string>intravaginal administration</json:string><json:string>biomol chem</json:string><json:string>heparan sulfate proteoglycan</json:string><json:string>aminoacid sequence</json:string><json:string>klebsiella oxytoca</json:string><json:string>natural galactosylceramide</json:string><json:string>human cell line</json:string><json:string>vero cell line</json:string><json:string>guinea pig</json:string><json:string>lateral chain</json:string><json:string>human immunodeficiency virus</json:string><json:string>endothelial cell</json:string><json:string>virucidal activity</json:string><json:string>host receptor</json:string><json:string>sulfated oligosaccharide cluster</json:string><json:string>immunocompromised individual</json:string><json:string>viral infection</json:string><json:string>high cytotoxicity</json:string><json:string>peptidic dendrimers</json:string><json:string>octavalent lysine core</json:string><json:string>human erythrocyte</json:string><json:string>naphthalene disulfonic acid</json:string><json:string>coli strain</json:string><json:string>gramnegative bacteria</json:string><json:string>antibacterial potency</json:string><json:string>escherichia coli</json:string><json:string>core molecule</json:string><json:string>core compound</json:string><json:string>sugar moiety</json:string><json:string>multiwalled carbon nanotube</json:string><json:string>silver nanoparticles</json:string><json:string>various moiety</json:string><json:string>bacterial lipopolysaccharide</json:string><json:string>amine group</json:string><json:string>synergistic action</json:string><json:string>antimicrobial drug</json:string><json:string>antibacterial effect</json:string><json:string>monomeric branch</json:string><json:string>pseudomonas aeruginosa biofilms</json:string><json:string>main family</json:string><json:string>dade behring</json:string><json:string>phosphorus atom</json:string><json:string>acute care</json:string><json:string>intensive study</json:string><json:string>sialic acid derivative</json:string><json:string>angew chem</json:string><json:string>polyamidoamine dendrimers</json:string><json:string>transfection reagent</json:string><json:string>different origin</json:string><json:string>carbosilane dendrimer core scaffold</json:string><json:string>divergent method</json:string><json:string>influenza neuraminidase inhibitor</json:string><json:string>several advantage</json:string><json:string>human papillomaviruses</json:string><json:string>bacterial growth</json:string><json:string>drug carrier</json:string><json:string>microbicide candidate</json:string><json:string>biomed mater</json:string><json:string>bioconjugate chem</json:string><json:string>intensive research</json:string><json:string>chem biol</json:string><json:string>glioma cell</json:string><json:string>hydroxyl group</json:string><json:string>proc natl acad</json:string><json:string>colloid surf</json:string><json:string>microbiol immunol</json:string><json:string>glycopeptide dendrimers</json:string><json:string>virus</json:string><json:string>molecule</json:string><json:string>vero</json:string><json:string>wiley</json:string><json:string>disruption</json:string></teeft></keywords><author><json:item><name>Joanna Lazniewska</name><affiliations><json:string>Department of General Biophysics, University of Lodz, Lodz, Poland</json:string><json:string>E-mail: joanna.lazn@gmail.com</json:string><json:string>Correspondence address: Department of General Biophysics, University of Lodz, Lodz, Poland</json:string></affiliations></json:item><json:item><name>Katarzyna Milowska</name><affiliations><json:string>Department of General Biophysics, University of Lodz, Lodz, Poland</json:string></affiliations></json:item><json:item><name>Teresa Gabryelak</name><affiliations><json:string>Department of General Biophysics, University of Lodz, Lodz, Poland</json:string></affiliations></json:item></author><articleId><json:string>WNAN1181</json:string></articleId><arkIstex>ark:/67375/WNG-GGNMRLN8-Z</arkIstex><language><json:string>eng</json:string></language><originalGenre><json:string>reviewArticle</json:string></originalGenre><abstract>Over recent years innovative nanomolecules in a form of dendrimers have been gaining increasing interest. These compounds can be designed and modified in many ways giving a molecule which meets required expectations. For this reason dendrimers are the object of intensive studies in many fields of nanoscience including one of the most thriving—biomedicine. Numerous studies provide evidence that some dendrimers exhibit activities against many species/strains of viruses, bacteria, fungi, and prions. These types of dendritic nanostructures which are distinguished by antipathogenic properties and low cytotoxicity to eukaryotic cells may be potentially applied in medicine as novel drugs for various infectious diseases, especially those which are persistent, marked by high mortality rate, or untreatable. Dendrimers can exert their effect via different mechanisms of action, which are, in most cases, related to multivalency of the nanomolecule. The application of dendrimers is likely to be a breakthrough in prevention and treatment of infectious diseases which still beset humanity and may significantly improve the quality of people's life. WIREs Nanomed Nanobiotechnol 2012, 4:469–491. doi: 10.1002/wnan.1181 For further resources related to this article, please visit the WIREs website.</abstract><qualityIndicators><score>9.196</score><pdfWordCount>11604</pdfWordCount><pdfCharCount>83235</pdfCharCount><pdfVersion>1.3</pdfVersion><pdfPageCount>23</pdfPageCount><pdfPageSize>594 x 783 pts</pdfPageSize><pdfWordsPerPage>505</pdfWordsPerPage><pdfText>true</pdfText><refBibsNative>true</refBibsNative><abstractWordCount>183</abstractWordCount><abstractCharCount>1296</abstractCharCount><keywordCount>0</keywordCount></qualityIndicators><title>Dendrimers—revolutionary drugs for infectious diseases</title><pmid><json:string>22761054</json:string></pmid><genre><json:string>review-article</json:string></genre><host><title>Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology</title><language><json:string>unknown</json:string></language><doi><json:string>10.1002/(ISSN)1939-0041</json:string></doi><issn><json:string>1939-5116</json:string></issn><eissn><json:string>1939-0041</json:string></eissn><publisherId><json:string>WNAN</json:string></publisherId><volume>4</volume><issue>5</issue><pages><first>469</first><last>491</last><total>23</total></pages><genre><json:string>journal</json:string></genre><subject><json:item><value>Nanomedicine for Infectious Disease</value></json:item><json:item><value>Overview</value></json:item><json:item><value>Overview</value></json:item></subject></host><namedEntities><unitex><date><json:string>2012</json:string><json:string>1980</json:string></date><geogName></geogName><orgName><json:string>Wiley Periodicals, Inc.</json:string><json:string>UNAIDS</json:string><json:string>Department of General Biophysics, University of Lodz, Lodz, Poland Volume</json:string><json:string>Wiley Periodicals, Inc</json:string></orgName><orgName_funder></orgName_funder><orgName_provider></orgName_provider><persName></persName><placeName><json:string>Germany</json:string><json:string>Toxicity</json:string><json:string>Darmstadt</json:string></placeName><ref_url></ref_url><ref_bibl></ref_bibl><bibl></bibl></unitex></namedEntities><ark><json:string>ark:/67375/WNG-GGNMRLN8-Z</json:string></ark><categories><wos><json:string>1 - science</json:string><json:string>2 - nanoscience & nanotechnology</json:string><json:string>2 - medicine, research & experimental</json:string></wos><scienceMetrix><json:string>1 - applied sciences</json:string><json:string>2 - enabling & strategic technologies</json:string><json:string>3 - nanoscience & nanotechnology</json:string></scienceMetrix><scopus></scopus><inist><json:string>1 - sciences appliquees, technologies et medecines</json:string><json:string>2 - sciences biologiques et medicales</json:string><json:string>3 - sciences medicales</json:string></inist></categories><publicationDate>2012</publicationDate><copyrightDate>2012</copyrightDate><doi><json:string>10.1002/wnan.1181</json:string></doi><id>9831976E5B4267DD17E6ED28BFECEFD141B6FED3</id><score>1</score><fulltext><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-GGNMRLN8-Z/fulltext.pdf</uri></json:item><json:item><extension>zip</extension><original>false</original><mimetype>application/zip</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-GGNMRLN8-Z/bundle.zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/ark:/67375/WNG-GGNMRLN8-Z/fulltext.tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main">Dendrimers—revolutionary drugs for infectious diseases</title><title level="a" type="short" xml:lang="en">Dendrimers—revolutionary drugs for infectious diseases</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>John Wiley & Sons, Inc.</publisher><pubPlace>Hoboken, USA</pubPlace><availability><licence>Copyright © 2012 Wiley Periodicals, Inc.</licence></availability><date type="published" when="2012-09"></date></publicationStmt><notesStmt><note type="content-type" subtype="review-article" source="reviewArticle" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-L5L7X3NF-P">review-article</note><note type="publication-type" subtype="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note></notesStmt><sourceDesc><biblStruct type="review-article"><analytic><title level="a" type="main">Dendrimers—revolutionary drugs for infectious diseases</title><title level="a" type="short" xml:lang="en">Dendrimers—revolutionary drugs for infectious diseases</title><author xml:id="author-0000" role="corresp"><persName><forename type="first">Joanna</forename><surname>Lazniewska</surname></persName><email>joanna.lazn@gmail.com</email><affiliation><orgName type="division">Department of General Biophysics</orgName><orgName type="institution">University of Lodz</orgName><address><addrLine>Lodz</addrLine><addrLine>Poland</addrLine><country key="PL" xml:lang="en">POLAND</country></address></affiliation></author><author xml:id="author-0001"><persName><forename type="first">Katarzyna</forename><surname>Milowska</surname></persName><affiliation><orgName type="division">Department of General Biophysics</orgName><orgName type="institution">University of Lodz</orgName><address><addrLine>Lodz</addrLine><addrLine>Poland</addrLine><country key="PL" xml:lang="en">POLAND</country></address></affiliation></author><author xml:id="author-0002"><persName><forename type="first">Teresa</forename><surname>Gabryelak</surname></persName><affiliation><orgName type="division">Department of General Biophysics</orgName><orgName type="institution">University of Lodz</orgName><address><addrLine>Lodz</addrLine><addrLine>Poland</addrLine><country key="PL" xml:lang="en">POLAND</country></address></affiliation></author><idno type="istex">9831976E5B4267DD17E6ED28BFECEFD141B6FED3</idno><idno type="ark">ark:/67375/WNG-GGNMRLN8-Z</idno><idno type="DOI">10.1002/wnan.1181</idno><idno type="unit">WNAN1181</idno><idno type="toTypesetVersion">file:WNAN.WNAN1181.pdf</idno></analytic><monogr><title level="j" type="main">Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology</title><title level="j" type="alt">WILEY INTERDISCIPLINARY REVIEWS: NANOMEDICINE AND NANOBIOTECHNOLOGY</title><idno type="pISSN">1939-5116</idno><idno type="eISSN">1939-0041</idno><idno type="book-DOI">10.1002/(ISSN)1939-0041</idno><idno type="book-part-DOI">10.1002/wnan.v4.5</idno><idno type="product">WNAN</idno><imprint><biblScope unit="vol">4</biblScope><biblScope unit="issue">5</biblScope><biblScope unit="page" from="469">469</biblScope><biblScope unit="page" to="491">491</biblScope><biblScope unit="page-count">23</biblScope><publisher>John Wiley & Sons, Inc.</publisher><pubPlace>Hoboken, USA</pubPlace><date type="published" when="2012-09"></date></imprint></monogr></biblStruct></sourceDesc></fileDesc><encodingDesc><schemaRef type="ODD" url="https://xml-schema.delivery.istex.fr/tei-istex.odd"></schemaRef><appInfo><application ident="pub2tei" version="1.0.10" when="2019-12-20"><label>pub2TEI-ISTEX</label><desc>A set of style sheets for converting XML documents encoded in various scientific publisher formats into a common TEI format.
<ref target="http://www.tei-c.org/">We use TEI</ref></desc></application></appInfo></encodingDesc><profileDesc><abstract xml:lang="en" style="main"><head>Abstract</head><p>Over recent years innovative nanomolecules in a form of dendrimers have been gaining increasing interest. These compounds can be designed and modified in many ways giving a molecule which meets required expectations. For this reason dendrimers are the object of intensive studies in many fields of nanoscience including one of the most thriving—biomedicine. Numerous studies provide evidence that some dendrimers exhibit activities against many species/strains of viruses, bacteria, fungi, and prions. These types of dendritic nanostructures which are distinguished by antipathogenic properties and low cytotoxicity to eukaryotic cells may be potentially applied in medicine as novel drugs for various infectious diseases, especially those which are persistent, marked by high mortality rate, or untreatable. Dendrimers can exert their effect via different mechanisms of action, which are, in most cases, related to multivalency of the nanomolecule. The application of dendrimers is likely to be a breakthrough in prevention and treatment of infectious diseases which still beset humanity and may significantly improve the quality of people's life. <hi rend="italic">WIREs Nanomed Nanobiotechnol</hi> 2012, 4:469–491. doi: 10.1002/wnan.1181</p><p>For further resources related to this article, please visit the <ref type="url">http://wires.wiley.com/remdoi.cgi?doi=10.1002/wnan.1181</ref>.</p></abstract><textClass><keywords rend="articleCategory"><term>Overview</term></keywords><keywords rend="tocHeading1"><term>Overview</term></keywords></textClass><textClass><keywords ana="subject"><term ref="psi.wiley.com/subject/19395116/2NID">Nanomedicine for Infectious Disease</term></keywords></textClass><langUsage><language ident="en"></language></langUsage></profileDesc><revisionDesc><change when="2019-12-20" who="#istex" xml:id="pub2tei">formatting</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><extension>txt</extension><original>false</original><mimetype>text/plain</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-GGNMRLN8-Z/fulltext.txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>John Wiley & Sons, Inc.</publisherName><publisherLoc>Hoboken, USA</publisherLoc></publisherInfo><doi registered="yes">10.1002/(ISSN)1939-0041</doi><issn type="print">1939-5116</issn><issn type="electronic">1939-0041</issn><idGroup><id type="product" value="WNAN"></id></idGroup><titleGroup><title type="main" xml:lang="en" sort="WILEY INTERDISCIPLINARY REVIEWS: NANOMEDICINE AND NANOBIOTECHNOLOGY">Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology</title><title type="short">WIREs Nanomed Nanobiotechnol</title></titleGroup></publicationMeta><publicationMeta level="part" position="50"><doi origin="wiley" registered="yes">10.1002/wnan.v4.5</doi><numberingGroup><numbering type="journalVolume" number="4">4</numbering><numbering type="journalIssue">5</numbering></numberingGroup><coverDate startDate="2012-09">September/October 2012</coverDate></publicationMeta><publicationMeta level="unit" type="reviewArticle" position="2" status="forIssue"><doi origin="wiley" registered="yes">10.1002/wnan.1181</doi><idGroup><id type="unit" value="WNAN1181"></id></idGroup><countGroup><count type="pageTotal" number="23"></count></countGroup><titleGroup><title type="articleCategory">Overview</title><title type="tocHeading1">Overview</title></titleGroup><copyright ownership="publisher">Copyright © 2012 Wiley Periodicals, Inc.</copyright><eventGroup><event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:3.1.6 mode:FullText" date="2012-08-17"></event><event type="publishedOnlineEarlyUnpaginated" date="2012-07-03"></event><event type="firstOnline" date="2012-07-03"></event><event type="publishedOnlineFinalForm" date="2012-08-17"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-10"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.3.4 mode:FullText" date="2015-02-24"></event></eventGroup><numberingGroup><numbering type="pageFirst">469</numbering><numbering type="pageLast">491</numbering></numberingGroup><correspondenceTo>Department of General Biophysics, University of Lodz, Lodz, Poland</correspondenceTo><subjectInfo><subject href="psi.wiley.com/subject/19395116/2NID">Nanomedicine for Infectious Disease</subject></subjectInfo><linkGroup><link type="toTypesetVersion" href="file:WNAN.WNAN1181.pdf"></link></linkGroup></publicationMeta><contentMeta><countGroup><count type="figureTotal" number="11"></count><count type="tableTotal" number="1"></count><count type="referenceTotal" number="131"></count></countGroup><titleGroup><title type="main" xml:lang="en">Dendrimers—revolutionary drugs for infectious diseases</title><title type="short" xml:lang="en">Dendrimers—revolutionary drugs for infectious diseases</title></titleGroup><creators><creator xml:id="au1" creatorRole="author" affiliationRef="#af1" corresponding="yes"><personName><givenNames>Joanna</givenNames><familyName>Lazniewska</familyName></personName><contactDetails><email>joanna.lazn@gmail.com</email></contactDetails></creator><creator xml:id="au2" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Katarzyna</givenNames><familyName>Milowska</familyName></personName></creator><creator xml:id="au3" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Teresa</givenNames><familyName>Gabryelak</familyName></personName></creator></creators><affiliationGroup><affiliation xml:id="af1" countryCode="PL" type="organization"><unparsedAffiliation>Department of General Biophysics, University of Lodz, Lodz, Poland</unparsedAffiliation></affiliation></affiliationGroup><abstractGroup><abstract type="main" xml:lang="en"><title type="main">Abstract</title><p>Over recent years innovative nanomolecules in a form of dendrimers have been gaining increasing interest. These compounds can be designed and modified in many ways giving a molecule which meets required expectations. For this reason dendrimers are the object of intensive studies in many fields of nanoscience including one of the most thriving—biomedicine. Numerous studies provide evidence that some dendrimers exhibit activities against many species/strains of viruses, bacteria, fungi, and prions. These types of dendritic nanostructures which are distinguished by antipathogenic properties and low cytotoxicity to eukaryotic cells may be potentially applied in medicine as novel drugs for various infectious diseases, especially those which are persistent, marked by high mortality rate, or untreatable. Dendrimers can exert their effect via different mechanisms of action, which are, in most cases, related to multivalency of the nanomolecule. The application of dendrimers is likely to be a breakthrough in prevention and treatment of infectious diseases which still beset humanity and may significantly improve the quality of people's life. <i>WIREs Nanomed Nanobiotechnol</i> 2012, 4:469–491. doi: 10.1002/wnan.1181</p><p>For further resources related to this article, please visit the <url href="http://wires.wiley.com/remdoi.cgi?doi=10.1002/wnan.1181">WIREs website</url>.</p></abstract></abstractGroup></contentMeta></header></component></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Dendrimers—revolutionary drugs for infectious diseases</title></titleInfo><titleInfo type="abbreviated" lang="en"><title>Dendrimers—revolutionary drugs for infectious diseases</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Dendrimers—revolutionary drugs for infectious diseases</title></titleInfo><name type="personal"><namePart type="given">Joanna</namePart><namePart type="family">Lazniewska</namePart><affiliation>Department of General Biophysics, University of Lodz, Lodz, Poland</affiliation><affiliation>E-mail: joanna.lazn@gmail.com</affiliation><affiliation>Correspondence address: Department of General Biophysics, University of Lodz, Lodz, Poland</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Katarzyna</namePart><namePart type="family">Milowska</namePart><affiliation>Department of General Biophysics, University of Lodz, Lodz, Poland</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Teresa</namePart><namePart type="family">Gabryelak</namePart><affiliation>Department of General Biophysics, University of Lodz, Lodz, Poland</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="review-article" displayLabel="reviewArticle" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-L5L7X3NF-P">review-article</genre><originInfo><publisher>John Wiley & Sons, Inc.</publisher><place><placeTerm type="text">Hoboken, USA</placeTerm></place><dateIssued encoding="w3cdtf">2012-09</dateIssued><copyrightDate encoding="w3cdtf">2012</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><extent unit="figures">11</extent><extent unit="tables">1</extent><extent unit="references">131</extent></physicalDescription><abstract lang="en">Over recent years innovative nanomolecules in a form of dendrimers have been gaining increasing interest. These compounds can be designed and modified in many ways giving a molecule which meets required expectations. For this reason dendrimers are the object of intensive studies in many fields of nanoscience including one of the most thriving—biomedicine. Numerous studies provide evidence that some dendrimers exhibit activities against many species/strains of viruses, bacteria, fungi, and prions. These types of dendritic nanostructures which are distinguished by antipathogenic properties and low cytotoxicity to eukaryotic cells may be potentially applied in medicine as novel drugs for various infectious diseases, especially those which are persistent, marked by high mortality rate, or untreatable. Dendrimers can exert their effect via different mechanisms of action, which are, in most cases, related to multivalency of the nanomolecule. The application of dendrimers is likely to be a breakthrough in prevention and treatment of infectious diseases which still beset humanity and may significantly improve the quality of people's life. WIREs Nanomed Nanobiotechnol 2012, 4:469–491. doi: 10.1002/wnan.1181 For further resources related to this article, please visit the WIREs website.</abstract><relatedItem type="host"><titleInfo><title>Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology</title></titleInfo><titleInfo type="abbreviated"><title>WIREs Nanomed Nanobiotechnol</title></titleInfo><genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre><subject><genre>index-terms</genre><topic authorityURI="psi.wiley.com/subject/19395116/2NID">Nanomedicine for Infectious Disease</topic></subject><subject><genre>article-category</genre><topic>Overview</topic><topic>Overview</topic></subject><identifier type="ISSN">1939-5116</identifier><identifier type="eISSN">1939-0041</identifier><identifier type="DOI">10.1002/(ISSN)1939-0041</identifier><identifier type="PublisherID">WNAN</identifier><part><date>2012</date><detail type="volume"><caption>vol.</caption><number>4</number></detail><detail type="issue"><caption>no.</caption><number>5</number></detail><extent unit="pages"><start>469</start><end>491</end><total>23</total></extent></part></relatedItem><relatedItem type="references" displayLabel="cit1"><titleInfo><title>Cascade‐ and nonskid‐chain‐like syntheses of molecular cavity topologies.</title></titleInfo><name type="personal"><namePart type="given">E</namePart><namePart type="family">Buhleier</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">W</namePart><namePart type="family">Wehner</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F.</namePart><namePart type="family">Vögtle</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Buhleier E, Wehner W, Vögtle F. Cascade‐ and nonskid‐chain‐like syntheses of molecular cavity topologies. Synthesis 1978, 2:155–158.</note><part><date>1978</date><detail type="volume"><caption>vol.</caption><number>2</number></detail><extent unit="pages"><start>155</start><end>158.</end></extent></part><relatedItem type="host"><titleInfo><title>Synthesis</title></titleInfo><part><date>1978</date><detail type="volume"><caption>vol.</caption><number>2</number></detail><extent unit="pages"><start>155</start><end>158.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit2"><titleInfo><title>A new class of polymers: starburst‐dendritic macromolecules.</title></titleInfo><name type="personal"><namePart type="given">DA</namePart><namePart type="family">Tomalia</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H</namePart><namePart type="family">Baker</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Dewald</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Hall</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G</namePart><namePart type="family">Kallos</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Martin</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Roeck</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Ryder</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P.</namePart><namePart type="family">Smith</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Tomalia DA, Baker H, Dewald J, Hall M, Kallos G, Martin S, Roeck J, Ryder J, Smith P. A new class of polymers: starburst‐dendritic macromolecules. Polym J 1985, 17:117–132.</note><part><date>1985</date><detail type="volume"><caption>vol.</caption><number>17</number></detail><extent unit="pages"><start>117</start><end>132.</end></extent></part><relatedItem type="host"><titleInfo><title>Polym J</title></titleInfo><part><date>1985</date><detail type="volume"><caption>vol.</caption><number>17</number></detail><extent unit="pages"><start>117</start><end>132.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit3"><titleInfo><title>Dendrimers: properties and applications.</title></titleInfo><name type="personal"><namePart type="given">B</namePart><namePart type="family">Klajnert</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Bryszewska</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Klajnert B, Bryszewska M. Dendrimers: properties and applications. Acta Biochim Pol 2001, 48:199–208.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>48</number></detail><extent unit="pages"><start>199</start><end>208.</end></extent></part><relatedItem type="host"><titleInfo><title>Acta Biochim Pol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>48</number></detail><extent unit="pages"><start>199</start><end>208.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit4"><titleInfo><title>Dendrimers in biomedical applications—reflections on the field.</title></titleInfo><name type="personal"><namePart type="given">S</namePart><namePart type="family">Svenson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">DA.</namePart><namePart type="family">Tomalia</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Svenson S, Tomalia DA. Dendrimers in biomedical applications—reflections on the field. Adv Drug Deliv Rev 2005, 57:2106–2129.</note><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>57</number></detail><extent unit="pages"><start>2106</start><end>2129.</end></extent></part><relatedItem type="host"><titleInfo><title>Adv Drug Deliv Rev</title></titleInfo><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>57</number></detail><extent unit="pages"><start>2106</start><end>2129.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit5"><titleInfo><title>Dendrimers: emerging polymers for drug‐delivery systems.</title></titleInfo><name type="personal"><namePart type="given">BK</namePart><namePart type="family">Nanjwade</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">HM</namePart><namePart type="family">Bechra</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">GK</namePart><namePart type="family">Derkar</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">FV</namePart><namePart type="family">Manvi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">VK.</namePart><namePart type="family">Nanjwade</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Nanjwade BK, Bechra HM, Derkar GK, Manvi FV, Nanjwade VK. Dendrimers: emerging polymers for drug‐delivery systems. Eur J Pharm Sci 2009, 38:185–196.</note><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>38</number></detail><extent unit="pages"><start>185</start><end>196.</end></extent></part><relatedItem type="host"><titleInfo><title>Eur J Pharm Sci</title></titleInfo><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>38</number></detail><extent unit="pages"><start>185</start><end>196.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit6"><titleInfo><title>“Lego” chemistry for the straightforward synthesis of dendrimers.</title></titleInfo><name type="personal"><namePart type="given">V</namePart><namePart type="family">Maraval</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Pyzowski</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AM</namePart><namePart type="family">Caminade</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JP.</namePart><namePart type="family">Majoral</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Maraval V, Pyzowski J, Caminade AM, Majoral JP. “Lego” chemistry for the straightforward synthesis of dendrimers. J Org Chem 2003, 68:6043–6046.</note><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>68</number></detail><extent unit="pages"><start>6043</start><end>6046.</end></extent></part><relatedItem type="host"><titleInfo><title>J Org Chem</title></titleInfo><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>68</number></detail><extent unit="pages"><start>6043</start><end>6046.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit7"><titleInfo><title>Efficiency and fidelity in a click‐chemistry route to triazole dendrimers by the copper(I)‐catalyzed ligation of azides and alkynes.</title></titleInfo><name type="personal"><namePart type="given">P</namePart><namePart type="family">Wu</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AK</namePart><namePart type="family">Feldman</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AK</namePart><namePart type="family">Nugent</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">CJ</namePart><namePart type="family">Hawker</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Scheel</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B</namePart><namePart type="family">Voit</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Pyun</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JMJ</namePart><namePart type="family">Fréchet</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">KB</namePart><namePart type="family">Sharpless</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">VV.</namePart><namePart type="family">Fokin</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Wu P, Feldman AK, Nugent AK, Hawker CJ, Scheel A, Voit B, Pyun J, Fréchet JMJ, Sharpless KB, Fokin VV. Efficiency and fidelity in a click‐chemistry route to triazole dendrimers by the copper(I)‐catalyzed ligation of azides and alkynes. Angew Chem Int Ed Engl 2004, 43:3928–3932.</note><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>43</number></detail><extent unit="pages"><start>3928</start><end>3932.</end></extent></part><relatedItem type="host"><titleInfo><title>Angew Chem Int Ed Engl</title></titleInfo><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>43</number></detail><extent unit="pages"><start>3928</start><end>3932.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit8"><titleInfo><title>Birth of a new macromolecular architecture: dendrimers as quantized building blocks for nanoscale synthetic organic chemistry.</title></titleInfo><name type="personal"><namePart type="given">DA.</namePart><namePart type="family">Tomalia</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Tomalia DA. Birth of a new macromolecular architecture: dendrimers as quantized building blocks for nanoscale synthetic organic chemistry. Aldrichim Acta 2004, 37:39–57.</note><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>37</number></detail><extent unit="pages"><start>39</start><end>57.</end></extent></part><relatedItem type="host"><titleInfo><title>Aldrichim Acta</title></titleInfo><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>37</number></detail><extent unit="pages"><start>39</start><end>57.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit9"><titleInfo><title>Bioinspired application of dendrimers: from bio‐mimicry to biomedical applications.</title></titleInfo><name type="personal"><namePart type="given">WD</namePart><namePart type="family">Jang</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">KM</namePart><namePart type="family">Kamruzzaman Selim</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">CH</namePart><namePart type="family">Lee</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">IK.</namePart><namePart type="family">Kang</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Jang WD, Kamruzzaman Selim KM, Lee CH, Kang IK. Bioinspired application of dendrimers: from bio‐mimicry to biomedical applications. Prog Polym Sci 2008, 34:1–23.</note><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>34</number></detail><extent unit="pages"><start>1</start><end>23.</end></extent></part><relatedItem type="host"><titleInfo><title>Prog Polym Sci</title></titleInfo><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>34</number></detail><extent unit="pages"><start>1</start><end>23.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit10"><titleInfo><title>Dendrimer toxicity: let's meet the challenge.</title></titleInfo><name type="personal"><namePart type="given">K</namePart><namePart type="family">Jain</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P</namePart><namePart type="family">Kesharwani</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">U</namePart><namePart type="family">Gupta</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">NK.</namePart><namePart type="family">Jain</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Jain K, Kesharwani P, Gupta U, Jain NK. Dendrimer toxicity: let's meet the challenge. Int J Pharm 2010, 394:122–142.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>394</number></detail><extent unit="pages"><start>122</start><end>142.</end></extent></part><relatedItem type="host"><titleInfo><title>Int J Pharm</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>394</number></detail><extent unit="pages"><start>122</start><end>142.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit11"><titleInfo><title>Dendrimers and dendritic polymers as anti‐infective agents: new antimicrobial strategies for therapeutic drugs.</title></titleInfo><name type="personal"><namePart type="given">J</namePart><namePart type="family">Rojo</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R.</namePart><namePart type="family">Delgado</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Rojo J, Delgado R. Dendrimers and dendritic polymers as anti‐infective agents: new antimicrobial strategies for therapeutic drugs. Anti‐Infect Agents Med Chem 2007, 6:151–174.</note><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>6</number></detail><extent unit="pages"><start>151</start><end>174.</end></extent></part><relatedItem type="host"><titleInfo><title>Anti‐Infect Agents Med Chem</title></titleInfo><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>6</number></detail><extent unit="pages"><start>151</start><end>174.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit12"><titleInfo><title>Dendrimers and derivatives as a potential therapeutic tool in regenerative medicine strategies—a review.</title></titleInfo><name type="personal"><namePart type="given">JM</namePart><namePart type="family">Oliveira</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AJ</namePart><namePart type="family">Salgado</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">N</namePart><namePart type="family">Sousa</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JF</namePart><namePart type="family">Mano</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RL.</namePart><namePart type="family">Reis</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Oliveira JM, Salgado AJ, Sousa N, Mano JF, Reis RL. Dendrimers and derivatives as a potential therapeutic tool in regenerative medicine strategies—a review. Prog Polym Sci 2010, 35:1163–1194.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>35</number></detail><extent unit="pages"><start>1163</start><end>1194.</end></extent></part><relatedItem type="host"><titleInfo><title>Prog Polym Sci</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>35</number></detail><extent unit="pages"><start>1163</start><end>1194.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit13"><titleInfo><title>Dendrimer‐based drug and imaging conjugates: design considerations for nanomedical applications.</title></titleInfo><name type="personal"><namePart type="given">AR</namePart><namePart type="family">Menjoge</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RM</namePart><namePart type="family">Kannan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">DA.</namePart><namePart type="family">Tomalia</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Menjoge AR, Kannan RM, Tomalia DA. Dendrimer‐based drug and imaging conjugates: design considerations for nanomedical applications. Drug Discov Today 2010, 15:171–185.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>15</number></detail><extent unit="pages"><start>171</start><end>185.</end></extent></part><relatedItem type="host"><titleInfo><title>Drug Discov Today</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>15</number></detail><extent unit="pages"><start>171</start><end>185.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit14"><titleInfo><title>Surface modifications of nanocarriers for effective intracellular delivery of anti‐HIV drugs.</title></titleInfo><name type="personal"><namePart type="given">S</namePart><namePart type="family">Gunaseelan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">K</namePart><namePart type="family">Gunaseelan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Deshmukh</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">X</namePart><namePart type="family">Zhang</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">PJ.</namePart><namePart type="family">Sinko</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Gunaseelan S, Gunaseelan K, Deshmukh M, Zhang X, Sinko PJ. Surface modifications of nanocarriers for effective intracellular delivery of anti‐HIV drugs. Adv Drug Deliv Rev 2010, 62:518–531.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>62</number></detail><extent unit="pages"><start>518</start><end>531.</end></extent></part><relatedItem type="host"><titleInfo><title>Adv Drug Deliv Rev</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>62</number></detail><extent unit="pages"><start>518</start><end>531.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit15"><titleInfo><title>Pure drug and polymer based nanotechnologies for the improved solubility, stability, bioavailability and targeting of anti‐HIV drugs.</title></titleInfo><name type="personal"><namePart type="given">P</namePart><namePart type="family">Sharma</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.</namePart><namePart type="family">Garg</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Sharma P, Garg S. Pure drug and polymer based nanotechnologies for the improved solubility, stability, bioavailability and targeting of anti‐HIV drugs. Adv Drug Deliv Rev 2010, 62:491–502.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>62</number></detail><extent unit="pages"><start>491</start><end>502.</end></extent></part><relatedItem type="host"><titleInfo><title>Adv Drug Deliv Rev</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>62</number></detail><extent unit="pages"><start>491</start><end>502.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit16"><titleInfo><title>Interactions of a charged nanoparticle with a lipid membrane: implications for gene delivery.</title></titleInfo><name type="personal"><namePart type="given">CL</namePart><namePart type="family">Ting</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">ZG.</namePart><namePart type="family">Wang</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Ting CL, Wang ZG. Interactions of a charged nanoparticle with a lipid membrane: implications for gene delivery. Biophys J 2011, 100:1288–1297.</note><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>100</number></detail><extent unit="pages"><start>1288</start><end>1297.</end></extent></part><relatedItem type="host"><titleInfo><title>Biophys J</title></titleInfo><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>100</number></detail><extent unit="pages"><start>1288</start><end>1297.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit17"><titleInfo><title>Prevention of influenza pneumonitis by sialic acid‐conjugated dendritic polymers.</title></titleInfo><name type="personal"><namePart type="given">JJ</namePart><namePart type="family">Landers</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Z</namePart><namePart type="family">Cao</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">I</namePart><namePart type="family">Lee</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">LT</namePart><namePart type="family">Piehler</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">PP</namePart><namePart type="family">Myc</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Myc</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T</namePart><namePart type="family">Hamouda</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AT</namePart><namePart type="family">Galecki</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JR.</namePart><namePart type="family">Baker Jr</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Landers JJ, Cao Z, Lee I, Piehler LT, Myc PP, Myc A, Hamouda T, Galecki AT, Baker Jr JR. Prevention of influenza pneumonitis by sialic acid‐conjugated dendritic polymers. J Infect Dis 2002, 186:1222–1230.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>186</number></detail><extent unit="pages"><start>1222</start><end>1230.</end></extent></part><relatedItem type="host"><titleInfo><title>J Infect Dis</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>186</number></detail><extent unit="pages"><start>1222</start><end>1230.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit18"><titleInfo><title>Neoglycoconjugates based on dendrimer poly(aminoamides).</title></titleInfo><name type="personal"><namePart type="given">DE</namePart><namePart type="family">Tsvetkov</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">PE</namePart><namePart type="family">Cheshev</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AB</namePart><namePart type="family">Tuzikov</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AA</namePart><namePart type="family">Chinarev</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">GV</namePart><namePart type="family">Pazynina</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MA</namePart><namePart type="family">Sablina</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AS</namePart><namePart type="family">Gambaryan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">NV</namePart><namePart type="family">Bovin</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R</namePart><namePart type="family">Rieben</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AS</namePart><namePart type="family">Shashkov</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">NE.</namePart><namePart type="family">Nifant'ev</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Tsvetkov DE, Cheshev PE, Tuzikov AB, Chinarev AA, Pazynina GV, Sablina MA, Gambaryan AS, Bovin NV, Rieben R, Shashkov AS, Nifant'ev NE. Neoglycoconjugates based on dendrimer poly(aminoamides). Russ J Bioorg Chem 2002, 28:470–486.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>28</number></detail><extent unit="pages"><start>470</start><end>486.</end></extent></part><relatedItem type="host"><titleInfo><title>Russ J Bioorg Chem</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>28</number></detail><extent unit="pages"><start>470</start><end>486.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit19"><titleInfo><title>Sialyl α(2→3) lactose clusters using carbosilane dendrimer core scaffolds as influenza hemagglutinin blockers.</title></titleInfo><name type="personal"><namePart type="given">H</namePart><namePart type="family">Oka</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T</namePart><namePart type="family">Onaga</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T</namePart><namePart type="family">Koyama</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">CT</namePart><namePart type="family">Guo</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Y</namePart><namePart type="family">Suzuki</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Y</namePart><namePart type="family">Esumi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">K</namePart><namePart type="family">Hatano</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D</namePart><namePart type="family">Terenuma</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">K.</namePart><namePart type="family">Matsuoka</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Oka H, Onaga T, Koyama T, Guo CT, Suzuki Y, Esumi Y, Hatano K, Terenuma D, Matsuoka K. Sialyl α(2→3) lactose clusters using carbosilane dendrimer core scaffolds as influenza hemagglutinin blockers. Bioorg Med Chem Lett 2008, 18:4405–4408.</note><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>18</number></detail><extent unit="pages"><start>4405</start><end>4408.</end></extent></part><relatedItem type="host"><titleInfo><title>Bioorg Med Chem Lett</title></titleInfo><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>18</number></detail><extent unit="pages"><start>4405</start><end>4408.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit20"><titleInfo><title>Systematic syntheses of influenza neuraminidase inhibitors: a series of carbosilane dendrimers uniformly functionalized with thioglycoside‐type sialic acid moieties.</title></titleInfo><name type="personal"><namePart type="given">JI</namePart><namePart type="family">Sakamoto</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T</namePart><namePart type="family">Koyama</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D</namePart><namePart type="family">Miyamoto</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Yingsakmongkon</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">KIP</namePart><namePart type="family">Hidari</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">W</namePart><namePart type="family">Jampangern</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T</namePart><namePart type="family">Suzuki</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Y</namePart><namePart type="family">Suzuki</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Y</namePart><namePart type="family">Esumi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T</namePart><namePart type="family">Nakamura</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Sakamoto JI, Koyama T, Miyamoto D, Yingsakmongkon S, Hidari KIP, Jampangern W, Suzuki T, Suzuki Y, Esumi Y, Nakamura T, et al. Systematic syntheses of influenza neuraminidase inhibitors: a series of carbosilane dendrimers uniformly functionalized with thioglycoside‐type sialic acid moieties. Bioorg Med Chem 2009, 17:5451–5464.</note><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>17</number></detail><extent unit="pages"><start>5451</start><end>5464.</end></extent></part><relatedItem type="host"><titleInfo><title>Bioorg Med Chem</title></titleInfo><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>17</number></detail><extent unit="pages"><start>5451</start><end>5464.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit21"><titleInfo><title>Thiosialoside clusters using carbosilane dendrimer core scaffolds as a new class of influenza neuraminidase inhibitors.</title></titleInfo><name type="personal"><namePart type="given">JI</namePart><namePart type="family">Sakamoto</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T</namePart><namePart type="family">Koyama</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D</namePart><namePart type="family">Miyamoto</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Yingsakmongkon</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">KIP</namePart><namePart type="family">Hidari</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">W</namePart><namePart type="family">Jampangern</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T</namePart><namePart type="family">Suzuki</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Y</namePart><namePart type="family">Suzuki</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Y</namePart><namePart type="family">Esumi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="family">Nakamura</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Sakamoto JI, Koyama T, Miyamoto D, Yingsakmongkon S, Hidari KIP, Jampangern W, Suzuki T, Suzuki Y, Esumi Y, Nakamura, et al. Thiosialoside clusters using carbosilane dendrimer core scaffolds as a new class of influenza neuraminidase inhibitors. Bioorg Med Chem 2007, 17:717–721.</note><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>17</number></detail><extent unit="pages"><start>717</start><end>721.</end></extent></part><relatedItem type="host"><titleInfo><title>Bioorg Med Chem</title></titleInfo><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>17</number></detail><extent unit="pages"><start>717</start><end>721.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit22"><titleInfo><title>Mannosyl glycodendritic structure inhibits DC‐SIGN‐mediated Ebola virus infection in cis and in trans.</title></titleInfo><name type="personal"><namePart type="given">F</namePart><namePart type="family">Lasala</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E</namePart><namePart type="family">Arce</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JR</namePart><namePart type="family">Otero</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Rojo</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R.</namePart><namePart type="family">Delgado</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Lasala F, Arce E, Otero JR, Rojo J, Delgado R. Mannosyl glycodendritic structure inhibits DC‐SIGN‐mediated Ebola virus infection in cis and in trans. Antimicrob Agents Chemother 2003, 47:3970–3972.</note><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>47</number></detail><extent unit="pages"><start>3970</start><end>3972.</end></extent></part><relatedItem type="host"><titleInfo><title>Antimicrob Agents Chemother</title></titleInfo><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>47</number></detail><extent unit="pages"><start>3970</start><end>3972.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit23"><titleInfo><title>Evidence of dual sites of action of dendrimers: SPL‐2999 inhibits both virus entry and late stages of herpes simplex virus replication.</title></titleInfo><name type="personal"><namePart type="given">Y</namePart><namePart type="family">Gong</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B</namePart><namePart type="family">Matthews</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D</namePart><namePart type="family">Cheung</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T</namePart><namePart type="family">Tam</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">I</namePart><namePart type="family">Gadawski</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D</namePart><namePart type="family">Leung</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G</namePart><namePart type="family">Holan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Raff</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.</namePart><namePart type="family">Sacks</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Gong Y, Matthews B, Cheung D, Tam T, Gadawski I, Leung D, Holan G, Raff J, Sacks S. Evidence of dual sites of action of dendrimers: SPL‐2999 inhibits both virus entry and late stages of herpes simplex virus replication. Antiviral Res 2002, 55:319–329.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>55</number></detail><extent unit="pages"><start>319</start><end>329.</end></extent></part><relatedItem type="host"><titleInfo><title>Antiviral Res</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>55</number></detail><extent unit="pages"><start>319</start><end>329.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit24"><titleInfo><title>Preclinical safety and efficacy assessments of dendrimer‐based (SPL7013) microbicide gel formulations in a nonhuman primate model.</title></titleInfo><name type="personal"><namePart type="given">DL</namePart><namePart type="family">Patton</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">YT</namePart><namePart type="family">Cosgrove Sweeny</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">TD</namePart><namePart type="family">McCarthy</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">SL.</namePart><namePart type="family">Hillier</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Patton DL, Cosgrove Sweeny YT, McCarthy TD, Hillier SL. Preclinical safety and efficacy assessments of dendrimer‐based (SPL7013) microbicide gel formulations in a nonhuman primate model. Antimicrob Agents Chemother 2006, 50:1696–1700.</note><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>50</number></detail><extent unit="pages"><start>1696</start><end>1700.</end></extent></part><relatedItem type="host"><titleInfo><title>Antimicrob Agents Chemother</title></titleInfo><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>50</number></detail><extent unit="pages"><start>1696</start><end>1700.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit25"><titleInfo><title>Safety, tolerability, and pharmacokinetics of SPL7013 gel (VivaGel): a dose ranging, phase I study.</title></titleInfo><name type="personal"><namePart type="given">J</namePart><namePart type="family">O'Loughlin</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">IY</namePart><namePart type="family">Millwood</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">HM</namePart><namePart type="family">McDonald</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">CF</namePart><namePart type="family">Price</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JM</namePart><namePart type="family">Kaldor</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JR.</namePart><namePart type="family">Paull</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">O'Loughlin J, Millwood IY, McDonald HM, Price CF, Kaldor JM, Paull JR. Safety, tolerability, and pharmacokinetics of SPL7013 gel (VivaGel): a dose ranging, phase I study. Sex Transm Dis 2010, 37:100–104.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>37</number></detail><extent unit="pages"><start>100</start><end>104.</end></extent></part><relatedItem type="host"><titleInfo><title>Sex Transm Dis</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>37</number></detail><extent unit="pages"><start>100</start><end>104.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit26"><titleInfo><title>Evaluation of dendrimer SPL7013, a lead microbicide candidate against herpes simplex viruses.</title></titleInfo><name type="personal"><namePart type="given">E</namePart><namePart type="family">Gong</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B</namePart><namePart type="family">Matthews</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T</namePart><namePart type="family">McCarthy</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Chu</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G</namePart><namePart type="family">Holan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Raff</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.</namePart><namePart type="family">Sacs</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Gong E, Matthews B, McCarthy T, Chu J, Holan G, Raff J, Sacs S. Evaluation of dendrimer SPL7013, a lead microbicide candidate against herpes simplex viruses. Antiviral Res 2005, 68:139–146.</note><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>68</number></detail><extent unit="pages"><start>139</start><end>146.</end></extent></part><relatedItem type="host"><titleInfo><title>Antiviral Res</title></titleInfo><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>68</number></detail><extent unit="pages"><start>139</start><end>146.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit27"><titleInfo><title>Structure activity relationship of dendrimer microbicides with dual action antiviral activity.</title></titleInfo><name type="personal"><namePart type="given">D</namePart><namePart type="family">Tyssen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">SA</namePart><namePart type="family">Henderson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Johnson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Sterjovski</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">K</namePart><namePart type="family">Moore</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">La</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Zanim</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Sonza</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P</namePart><namePart type="family">Karellas</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MP</namePart><namePart type="family">Giannis</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Tyssen D, Henderson SA, Johnson A, Sterjovski J, Moore K, La J, Zanim M, Sonza S, Karellas P, Giannis MP, et al. Structure activity relationship of dendrimer microbicides with dual action antiviral activity. PLoS One 2010, 5:e12309.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>5</number></detail><extent unit="pages"><start>e12309.</start></extent></part><relatedItem type="host"><titleInfo><title>PLoS One</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>5</number></detail><extent unit="pages"><start>e12309.</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit28"><titleInfo><title>Inhibition of Herpes simplex virus type 1 and type 2 infections by peptide‐derivatized dendrimers.</title></titleInfo><name type="personal"><namePart type="given">A</namePart><namePart type="family">Luganini</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">SF</namePart><namePart type="family">Nicoletto</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">L</namePart><namePart type="family">Pizzuto</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G</namePart><namePart type="family">Pirri</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Giuliani</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Landolfo</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G.</namePart><namePart type="family">Gribaudo</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Luganini A, Nicoletto SF, Pizzuto L, Pirri G, Giuliani A, Landolfo S, Gribaudo G. Inhibition of Herpes simplex virus type 1 and type 2 infections by peptide‐derivatized dendrimers. Antimicrob Agents Chemother 2011, 55:3231–3239.</note><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>55</number></detail><extent unit="pages"><start>3231</start><end>3239.</end></extent></part><relatedItem type="host"><titleInfo><title>Antimicrob Agents Chemother</title></titleInfo><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>55</number></detail><extent unit="pages"><start>3231</start><end>3239.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit29"><titleInfo><title>Peptide‐derivatized dendrimers inhibit human cytomegalovirus infection by blocking virus binding to cell surface heparan sulfate.</title></titleInfo><name type="personal"><namePart type="given">A</namePart><namePart type="family">Luganini</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Giuliani</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G</namePart><namePart type="family">Pirri</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">L</namePart><namePart type="family">Pizzuto</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Landolfo</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G.</namePart><namePart type="family">Gribaudo</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Luganini A, Giuliani A, Pirri G, Pizzuto L, Landolfo S, Gribaudo G. Peptide‐derivatized dendrimers inhibit human cytomegalovirus infection by blocking virus binding to cell surface heparan sulfate. Antiviral Res 2010, 85:532–540.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>85</number></detail><extent unit="pages"><start>532</start><end>540.</end></extent></part><relatedItem type="host"><titleInfo><title>Antiviral Res</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>85</number></detail><extent unit="pages"><start>532</start><end>540.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit30"><titleInfo><title>Identification of a dendrimeric heparan sulfate‐binding peptide that inhibits infectivity of genital types of human papillomaviruses.</title></titleInfo><name type="personal"><namePart type="given">M</namePart><namePart type="family">Donalisio</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Rusnati</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Civra</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Bugatti</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D</namePart><namePart type="family">Allemand</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G</namePart><namePart type="family">Pirri</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Giuliani</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Landolfo</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D.</namePart><namePart type="family">Lembo</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Donalisio M, Rusnati M, Civra A, Bugatti A, Allemand D, Pirri G, Giuliani A, Landolfo S, Lembo D. Identification of a dendrimeric heparan sulfate‐binding peptide that inhibits infectivity of genital types of human papillomaviruses. Antimicrob Agents Chemother 2010, 54:4290–4299.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>54</number></detail><extent unit="pages"><start>4290</start><end>4299.</end></extent></part><relatedItem type="host"><titleInfo><title>Antimicrob Agents Chemother</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>54</number></detail><extent unit="pages"><start>4290</start><end>4299.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit31"><titleInfo><title>Dendritic catanionic assemblies: in vitro anti‐HIV activity of phosphorus‐containing dendrimers bearing galβ1cer analogues.</title></titleInfo><name type="personal"><namePart type="given">M</namePart><namePart type="family">Blanzat</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">CO</namePart><namePart type="family">Turrin</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AM</namePart><namePart type="family">Aubertin</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C</namePart><namePart type="family">Couturier‐Vidal</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AM</namePart><namePart type="family">Caminade</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JP</namePart><namePart type="family">Majoral</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">I</namePart><namePart type="family">Rico‐Lattes</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A.</namePart><namePart type="family">Lattes</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Blanzat M, Turrin CO, Aubertin AM, Couturier‐Vidal C, Caminade AM, Majoral JP, Rico‐Lattes I, Lattes A. Dendritic catanionic assemblies: in vitro anti‐HIV activity of phosphorus‐containing dendrimers bearing galβ1cer analogues. Chembiochem 2005, 6: 2207–2213.</note><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>6</number></detail><extent unit="pages"><start>2207</start><end>2213.</end></extent></part><relatedItem type="host"><titleInfo><title>Chembiochem</title></titleInfo><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>6</number></detail><extent unit="pages"><start>2207</start><end>2213.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit32"><titleInfo><title>De novo daptomycin‐nonsusceptible enterococcal infections.</title></titleInfo><name type="personal"><namePart type="given">T</namePart><namePart type="family">Kelesidis</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R</namePart><namePart type="family">Humphries</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">DZ</namePart><namePart type="family">Uslan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D.</namePart><namePart type="family">Pegues</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Kelesidis T, Humphries R, Uslan DZ, Pegues D. De novo daptomycin‐nonsusceptible enterococcal infections. Emerging Infect Dis 2012, 18:674–676.</note><part><date>2012</date><detail type="volume"><caption>vol.</caption><number>18</number></detail><extent unit="pages"><start>674</start><end>676</end></extent></part><relatedItem type="host"><titleInfo><title>Emerging Infect Dis</title></titleInfo><part><date>2012</date><detail type="volume"><caption>vol.</caption><number>18</number></detail><extent unit="pages"><start>674</start><end>676</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit33"><titleInfo><title>Tigecycline‐resistant Enterococcus faecalis associated with omeprazole use in surgical patient.</title></titleInfo><name type="personal"><namePart type="given">C</namePart><namePart type="family">Cordina</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R</namePart><namePart type="family">Hill</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Deshpande</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H</namePart><namePart type="family">Hood</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T.</namePart><namePart type="family">Inkster</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Cordina C, Hill R, Deshpande A, Hood H, Inkster T. Tigecycline‐resistant Enterococcus faecalis associated with omeprazole use in surgical patient. J Antimicriob Chemoth 2012, 67:1806–1807.</note><part><date>2012</date><detail type="volume"><caption>vol.</caption><number>67</number></detail><extent unit="pages"><start>1806</start><end>1807</end></extent></part><relatedItem type="host"><titleInfo><title>J Antimicriob Chemoth</title></titleInfo><part><date>2012</date><detail type="volume"><caption>vol.</caption><number>67</number></detail><extent unit="pages"><start>1806</start><end>1807</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit34"><titleInfo><title>Antibacterial activities of poly(amidoamine) dendrimers terminated with amino and poly(ethylene glycol) groups.</title></titleInfo><name type="personal"><namePart type="given">MK</namePart><namePart type="family">Calabretta</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Kumar</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AM</namePart><namePart type="family">McDermott</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C.</namePart><namePart type="family">CCai</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Calabretta MK, Kumar A, McDermott AM, CCai C. Antibacterial activities of poly(amidoamine) dendrimers terminated with amino and poly(ethylene glycol) groups. Biomacromolecules 2007, 8:1807–1811.</note><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>8</number></detail><extent unit="pages"><start>1807</start><end>1811.</end></extent></part><relatedItem type="host"><titleInfo><title>Biomacromolecules</title></titleInfo><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>8</number></detail><extent unit="pages"><start>1807</start><end>1811.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit35"><titleInfo><title>Modality of bacterial growth presents unique targets: how do we treat biofilm‐mediated infections?</title></titleInfo><name type="personal"><namePart type="given">PD.</namePart><namePart type="family">Fey</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Fey PD. Modality of bacterial growth presents unique targets: how do we treat biofilm‐mediated infections? Curr Opin Microbiol 2010, 13:610–615.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>13</number></detail><extent unit="pages"><start>610</start><end>615.</end></extent></part><relatedItem type="host"><titleInfo><title>Curr Opin Microbiol</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>13</number></detail><extent unit="pages"><start>610</start><end>615.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit36"><titleInfo><title>Water‐stable ammonium‐terminated carbosilane dendrimers as efficient antibacterial agents.</title></titleInfo><name type="personal"><namePart type="given">B</namePart><namePart type="family">Rasines</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JM</namePart><namePart type="family">Hernández‐Ros</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">N</namePart><namePart type="family">de las Cuevas</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JL</namePart><namePart type="family">Copa‐Patiño</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Soliveri</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MA</namePart><namePart type="family">Muñez‐Fernandez</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R</namePart><namePart type="family">Gómez</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">FJ.</namePart><namePart type="family">de la Mata</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Rasines B, Hernández‐Ros JM, de las Cuevas N, Copa‐Patiño JL, Soliveri J, Muñez‐Fernandez MA, Gómez R, de la Mata FJ. Water‐stable ammonium‐terminated carbosilane dendrimers as efficient antibacterial agents. Dalton Trans 2009, 40:8704–8713.</note><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>40</number></detail><extent unit="pages"><start>8704</start><end>8713.</end></extent></part><relatedItem type="host"><titleInfo><title>Dalton Trans</title></titleInfo><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>40</number></detail><extent unit="pages"><start>8704</start><end>8713.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit37"><titleInfo><title>Pharmaceutical and biomedical potential of PEGylated dendrimers.</title></titleInfo><name type="personal"><namePart type="given">V</namePart><namePart type="family">Gajbhiye</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">PV</namePart><namePart type="family">Kumar</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RK</namePart><namePart type="family">Tekade</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">NK.</namePart><namePart type="family">Jain</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Gajbhiye V, Kumar PV, Tekade RK, Jain NK. Pharmaceutical and biomedical potential of PEGylated dendrimers. Curr Pharm Des 2007, 13:415–429.</note><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>13</number></detail><extent unit="pages"><start>415</start><end>429.</end></extent></part><relatedItem type="host"><titleInfo><title>Curr Pharm Des</title></titleInfo><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>13</number></detail><extent unit="pages"><start>415</start><end>429.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit38"><titleInfo><title>In vivo toxicity of poly(propyleneimine) dendrimers.</title></titleInfo><name type="personal"><namePart type="given">B</namePart><namePart type="family">Ziemba</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Janaszewska</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">K</namePart><namePart type="family">Ciepluch</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Krotewicz</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">WA</namePart><namePart type="family">Fogel</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D</namePart><namePart type="family">Appelhans</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B</namePart><namePart type="family">Voit</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Bryszewska</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B.</namePart><namePart type="family">Klajnert</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Ziemba B, Janaszewska A, Ciepluch K, Krotewicz M, Fogel WA, Appelhans D, Voit B, Bryszewska M, Klajnert B. In vivo toxicity of poly(propyleneimine) dendrimers. J Biomed Mater Res A 2011, 99:261–268.</note><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>99</number></detail><extent unit="pages"><start>261</start><end>268.</end></extent></part><relatedItem type="host"><titleInfo><title>J Biomed Mater Res A</title></titleInfo><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>99</number></detail><extent unit="pages"><start>261</start><end>268.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit39"><titleInfo><title>Surface acetylation of polyamidoamine (PAMAM) dendrimers decreases cytotoxicity while maintaining membrane permeability.</title></titleInfo><name type="personal"><namePart type="given">RB</namePart><namePart type="family">Kolhatkar</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">KM</namePart><namePart type="family">Kitchens</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">PW</namePart><namePart type="family">Swaan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H.</namePart><namePart type="family">Ghandehari</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Kolhatkar RB, Kitchens KM, Swaan PW, Ghandehari H. Surface acetylation of polyamidoamine (PAMAM) dendrimers decreases cytotoxicity while maintaining membrane permeability. Bioconjugate Chem 2007, 18:2054–2060.</note><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>18</number></detail><extent unit="pages"><start>2054</start><end>2060.</end></extent></part><relatedItem type="host"><titleInfo><title>Bioconjugate Chem</title></titleInfo><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>18</number></detail><extent unit="pages"><start>2054</start><end>2060.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit40"><titleInfo><title>Dendrimers as carriers for delivery of chemotherapeutic agents.</title></titleInfo><name type="personal"><namePart type="given">SH</namePart><namePart type="family">Medina</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MEH.</namePart><namePart type="family">El‐Sayed</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Medina SH, El‐Sayed MEH. Dendrimers as carriers for delivery of chemotherapeutic agents. Chem Rev 2009, 109:3141–3157.</note><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>109</number></detail><extent unit="pages"><start>3141</start><end>3157.</end></extent></part><relatedItem type="host"><titleInfo><title>Chem Rev</title></titleInfo><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>109</number></detail><extent unit="pages"><start>3141</start><end>3157.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit41"><titleInfo><title>The decrease of PAMAM dendrimer‐induced cytotoxicity by PEGylation via attenuation of oxidative stress.</title></titleInfo><name type="personal"><namePart type="given">W</namePart><namePart type="family">Wang</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">W</namePart><namePart type="family">Xiong</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Wan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">X</namePart><namePart type="family">Sun</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H</namePart><namePart type="family">Xu</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H.</namePart><namePart type="family">Yang</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Wang W, Xiong W, Wan J, Sun X, Xu H, Yang H. The decrease of PAMAM dendrimer‐induced cytotoxicity by PEGylation via attenuation of oxidative stress. Nanotechnology 2009, 20:105103.</note><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>20</number></detail><extent unit="pages"><start>105103.</start></extent></part><relatedItem type="host"><titleInfo><title>Nanotechnology</title></titleInfo><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>20</number></detail><extent unit="pages"><start>105103.</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit42"><titleInfo><title>Acetylation of PAMAM dendrimers for cellular delivery of siRNA.</title></titleInfo><name type="personal"><namePart type="given">CL</namePart><namePart type="family">Waite</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">SM</namePart><namePart type="family">Sparks</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">KE</namePart><namePart type="family">Uhrich</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">CM.</namePart><namePart type="family">Roth</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Waite CL, Sparks SM, Uhrich KE, Roth CM. Acetylation of PAMAM dendrimers for cellular delivery of siRNA. BMC Biotechnol 2009, 9:9–38.</note><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>9</number></detail><extent unit="pages"><start>9</start><end>38.</end></extent></part><relatedItem type="host"><titleInfo><title>BMC Biotechnol</title></titleInfo><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>9</number></detail><extent unit="pages"><start>9</start><end>38.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit43"><titleInfo><title>Evaluation of folate‐PAMAM for the delivery of antisense oligonucleotides to rat C6 glioma cells in vitro and in vivo.</title></titleInfo><name type="personal"><namePart type="given">C</namePart><namePart type="family">Kang</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">X</namePart><namePart type="family">Yuan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F</namePart><namePart type="family">Li</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P</namePart><namePart type="family">Pu</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Yu</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C</namePart><namePart type="family">Shen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Z</namePart><namePart type="family">Zhang</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Y.</namePart><namePart type="family">Zhang</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Kang C, Yuan X, Li F, Pu P, Yu S, Shen C, Zhang Z, Zhang Y. Evaluation of folate‐PAMAM for the delivery of antisense oligonucleotides to rat C6 glioma cells in vitro and in vivo. J Biomed Mater Res 2010, 93:585–594.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>93</number></detail><extent unit="pages"><start>585</start><end>594.</end></extent></part><relatedItem type="host"><titleInfo><title>J Biomed Mater Res</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>93</number></detail><extent unit="pages"><start>585</start><end>594.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit44"><titleInfo><title>Potentiation of fibroblast growth factor activity by synthetic heparin oligosaccharide glycodendrimers.</title></titleInfo><name type="personal"><namePart type="given">JL</namePart><namePart type="family">de Paz</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C</namePart><namePart type="family">Noti</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F</namePart><namePart type="family">Böhm</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Werner</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">PH.</namePart><namePart type="family">Seeberger</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">de Paz JL, Noti C, Böhm F, Werner S, Seeberger PH. Potentiation of fibroblast growth factor activity by synthetic heparin oligosaccharide glycodendrimers. Chem Biol 2007, 14:879–887.</note><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>14</number></detail><extent unit="pages"><start>879</start><end>887.</end></extent></part><relatedItem type="host"><titleInfo><title>Chem Biol</title></titleInfo><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>14</number></detail><extent unit="pages"><start>879</start><end>887.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit45"><titleInfo><title>Chemical induction of misfolded prion protein conformers in cell culture.</title></titleInfo><name type="personal"><namePart type="given">S</namePart><namePart type="family">Ghaemmaghami</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Ullman</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Ahn</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">St Martin</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">SB.</namePart><namePart type="family">Prusiner</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Ghaemmaghami S, Ullman J, Ahn M, St Martin S, Prusiner SB. Chemical induction of misfolded prion protein conformers in cell culture. J Biol Chem 2010, 285:10415–10423.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>285</number></detail><extent unit="pages"><start>10415</start><end>10423.</end></extent></part><relatedItem type="host"><titleInfo><title>J Biol Chem</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>285</number></detail><extent unit="pages"><start>10415</start><end>10423.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit46"><titleInfo><title>Discovery of dendrimers and dendritic polymers: a brief historical perspective.</title></titleInfo><name type="personal"><namePart type="given">DA</namePart><namePart type="family">Tomalia</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JMJ.</namePart><namePart type="family">Fréchet</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Tomalia DA, Fréchet JMJ. Discovery of dendrimers and dendritic polymers: a brief historical perspective. J Polym Sci Part A Polym Chem 2001, 40:2719–2728.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>40</number></detail><extent unit="pages"><start>2719</start><end>2728.</end></extent></part><relatedItem type="host"><titleInfo><title>J Polym Sci Part A Polym Chem</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>40</number></detail><extent unit="pages"><start>2719</start><end>2728.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit47"><titleInfo><title>Dendrimers: design, synthesis and chemical properties.</title></titleInfo><name type="personal"><namePart type="given">U</namePart><namePart type="family">Boas</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JB</namePart><namePart type="family">Christensen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">PMH.</namePart><namePart type="family">Heegaard</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Boas U, Christensen JB, Heegaard PMH. Dendrimers: design, synthesis and chemical properties. J Mater Chem 2006, 16:3785–3798.</note><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>16</number></detail><extent unit="pages"><start>3785</start><end>3798.</end></extent></part><relatedItem type="host"><titleInfo><title>J Mater Chem</title></titleInfo><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>16</number></detail><extent unit="pages"><start>3785</start><end>3798.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit48"><titleInfo><title>Glycodendrimeric nanoparticulate carriers of primaquine phosphate for liver targeting.</title></titleInfo><name type="personal"><namePart type="given">D</namePart><namePart type="family">Bhadra</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AK</namePart><namePart type="family">Yadav</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Bhadra</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">NK.</namePart><namePart type="family">Jain</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Bhadra D, Yadav AK, Bhadra S, Jain NK. Glycodendrimeric nanoparticulate carriers of primaquine phosphate for liver targeting. Int J Pharm 2005, 295:221–233.</note><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>295</number></detail><extent unit="pages"><start>221</start><end>233.</end></extent></part><relatedItem type="host"><titleInfo><title>Int J Pharm</title></titleInfo><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>295</number></detail><extent unit="pages"><start>221</start><end>233.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit49"><titleInfo><title>Cancer targeting potential of some ligand‐anchored poly(propylene imine) dendrimers: a comparison.</title></titleInfo><name type="personal"><namePart type="given">P</namePart><namePart type="family">Kesharwani</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RK</namePart><namePart type="family">Tekade</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">V</namePart><namePart type="family">Gajbhiye</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">K</namePart><namePart type="family">Jain</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">NK.</namePart><namePart type="family">Jain</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Kesharwani P, Tekade RK, Gajbhiye V, Jain K, Jain NK. Cancer targeting potential of some ligand‐anchored poly(propylene imine) dendrimers: a comparison. Nanomed Nanotech Biol Med 2011, 7:295–304.</note><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>7</number></detail><extent unit="pages"><start>295</start><end>304.</end></extent></part><relatedItem type="host"><titleInfo><title>Nanomed Nanotech Biol Med</title></titleInfo><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>7</number></detail><extent unit="pages"><start>295</start><end>304.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit50"><titleInfo><title>Guanidino‐ and urea‐modified dendrimers as potent solubilizers of misfolded prion protein aggregates under non‐cytotoxic conditions. Dependence on dendrimer generation and surface charge.</title></titleInfo><name type="personal"><namePart type="given">H</namePart><namePart type="family">Cordes</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">U</namePart><namePart type="family">Boas</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P</namePart><namePart type="family">Olsen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">PMH.</namePart><namePart type="family">Heegaard</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Cordes H, Boas U, Olsen P, Heegaard PMH. Guanidino‐ and urea‐modified dendrimers as potent solubilizers of misfolded prion protein aggregates under non‐cytotoxic conditions. Dependence on dendrimer generation and surface charge. Biomacromolecules 2007, 8:3578–3583.</note><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>8</number></detail><extent unit="pages"><start>3578</start><end>3583.</end></extent></part><relatedItem type="host"><titleInfo><title>Biomacromolecules</title></titleInfo><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>8</number></detail><extent unit="pages"><start>3578</start><end>3583.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit51"><titleInfo><title>Peptide dendrimers: applications and synthesis.</title></titleInfo><name type="personal"><namePart type="given">K</namePart><namePart type="family">Sadler</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JP.</namePart><namePart type="family">Tam</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Sadler K, Tam JP. Peptide dendrimers: applications and synthesis. Mol Biotechnol 2002, 90:195–229.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>90</number></detail><extent unit="pages"><start>195</start><end>229.</end></extent></part><relatedItem type="host"><titleInfo><title>Mol Biotechnol</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>90</number></detail><extent unit="pages"><start>195</start><end>229.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit52"><titleInfo><title>Macromolecular highly branched homogeneous compound based on lysine units.</title></titleInfo><name type="personal"><namePart type="given">RG</namePart><namePart type="family">Denkewalter</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Kolc</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">WJ.</namePart><namePart type="family">Lukasavage</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>other</genre><part><date>1981</date></part></relatedItem><relatedItem type="references" displayLabel="cit53"><titleInfo><title>A novel method for producing anti‐peptide antibodies. Production of site‐specific antibodies to the T cell antigen receptor beta‐chain</title></titleInfo><name type="personal"><namePart type="given">DN</namePart><namePart type="family">Posnett</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H</namePart><namePart type="family">McGrath</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JP.</namePart><namePart type="family">Tam</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Posnett DN, McGrath H, Tam JP. A novel method for producing anti‐peptide antibodies. Production of site‐specific antibodies to the T cell antigen receptor beta‐chain J Biol Chem 1988, 263:1719–1725.</note><part><date>1988</date><detail type="volume"><caption>vol.</caption><number>263</number></detail><extent unit="pages"><start>1719</start><end>1725.</end></extent></part><relatedItem type="host"><titleInfo><title>J Biol Chem</title></titleInfo><part><date>1988</date><detail type="volume"><caption>vol.</caption><number>263</number></detail><extent unit="pages"><start>1719</start><end>1725.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit54"><titleInfo><title>Synthetic peptide vaccine design: synthesis and properties of a high‐density multiple antigenic peptide system.</title></titleInfo><name type="personal"><namePart type="given">JP.</namePart><namePart type="family">Tam</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Tam JP. Synthetic peptide vaccine design: synthesis and properties of a high‐density multiple antigenic peptide system. Proc Natl Acad Sci USA 1988, 85:5409–5413.</note><part><date>1988</date><detail type="volume"><caption>vol.</caption><number>85</number></detail><extent unit="pages"><start>5409</start><end>5413.</end></extent></part><relatedItem type="host"><titleInfo><title>Proc Natl Acad Sci USA</title></titleInfo><part><date>1988</date><detail type="volume"><caption>vol.</caption><number>85</number></detail><extent unit="pages"><start>5409</start><end>5413.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit55"><titleInfo><title>New‐generation biomedical materials: peptide dendrimers and their application in biomedicine.</title></titleInfo><name type="personal"><namePart type="given">ZW</namePart><namePart type="family">Gu</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">K</namePart><namePart type="family">Luo</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">WC</namePart><namePart type="family">She</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Y</namePart><namePart type="family">Eu</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B.</namePart><namePart type="family">He</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Gu ZW, Luo K, She WC, Eu Y, He B. New‐generation biomedical materials: peptide dendrimers and their application in biomedicine. Sci China Chem 2010, 53:458–478.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>53</number></detail><extent unit="pages"><start>458</start><end>478.</end></extent></part><relatedItem type="host"><titleInfo><title>Sci China Chem</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>53</number></detail><extent unit="pages"><start>458</start><end>478.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit56"><titleInfo><title>Systemic antiangiogenic activity of cationic poly‐L‐lysine dendrimer delays tumor growth.</title></titleInfo><name type="personal"><namePart type="given">KT</namePart><namePart type="family">Al‐Jamal</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">WT</namePart><namePart type="family">Al‐Jamal</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Akerman</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JE</namePart><namePart type="family">Podesta</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Yilmazer</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JA</namePart><namePart type="family">Turton</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Bianco</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">N</namePart><namePart type="family">Vargesson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C</namePart><namePart type="family">Kanthou</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AT</namePart><namePart type="family">Florence</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Al‐Jamal KT, Al‐Jamal WT, Akerman S, Podesta JE, Yilmazer A, Turton JA, Bianco A, Vargesson N, Kanthou C, Florence AT, et al. Systemic antiangiogenic activity of cationic poly‐L‐lysine dendrimer delays tumor growth. Proc Natl Acad Sci USA 2010, 107:3966–3971.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>107</number></detail><extent unit="pages"><start>3966</start><end>3971.</end></extent></part><relatedItem type="host"><titleInfo><title>Proc Natl Acad Sci USA</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>107</number></detail><extent unit="pages"><start>3966</start><end>3971.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit57"><titleInfo><title>VivaGel (SPL7013 Gel): a candidate dendrimer—microbicide for the prevention of HIV and HSV infection.</title></titleInfo><name type="personal"><namePart type="given">R</namePart><namePart type="family">Rupp</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">SL</namePart><namePart type="family">Rosenthal</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">LR.</namePart><namePart type="family">Stanberry</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Rupp R, Rosenthal SL, Stanberry LR. VivaGel (SPL7013 Gel): a candidate dendrimer—microbicide for the prevention of HIV and HSV infection. Int J Nanomed 2007, 2:561–566.</note><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>2</number></detail><extent unit="pages"><start>561</start><end>566.</end></extent></part><relatedItem type="host"><titleInfo><title>Int J Nanomed</title></titleInfo><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>2</number></detail><extent unit="pages"><start>561</start><end>566.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit58"><titleInfo><title>Virucidal activity of the dendrimer microbicide SPL7013 against HIV‐1.</title></titleInfo><name type="personal"><namePart type="given">S</namePart><namePart type="family">Telwatte</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">K</namePart><namePart type="family">Moore</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Johnson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D</namePart><namePart type="family">Tyssen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Sterjovski</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Aldunate</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">PR</namePart><namePart type="family">Gorry</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">PA</namePart><namePart type="family">Ramsland</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">GR</namePart><namePart type="family">Lewis</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JRA</namePart><namePart type="family">Paull</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Telwatte S, Moore K, Johnson A, Tyssen D, Sterjovski J, Aldunate M, Gorry PR, Ramsland PA, Lewis GR, Paull JRA, et al. Virucidal activity of the dendrimer microbicide SPL7013 against HIV‐1. Antiviral Res 2011, 90:195–199.</note><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>90</number></detail><extent unit="pages"><start>195</start><end>199.</end></extent></part><relatedItem type="host"><titleInfo><title>Antiviral Res</title></titleInfo><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>90</number></detail><extent unit="pages"><start>195</start><end>199.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit59"><titleInfo><title>http://clinicaltrials.gov/ct2/show/NCT01437722 (Accessed March 30, 2012).</title></titleInfo><genre>other</genre><part><date>2012</date></part></relatedItem><relatedItem type="references" displayLabel="cit60"><titleInfo><title>http://clinicaltrials.gov/ct2/show/NCT01201057 (Accessed March 30, 2012).</title></titleInfo><genre>other</genre><part><date>2012</date></part></relatedItem><relatedItem type="references" displayLabel="cit61"><titleInfo><title>http://clinicaltrials.gov/ct2/results?term=vivagel (Accessed March 30, 2012).</title></titleInfo><genre>other</genre><part><date>2012</date></part></relatedItem><relatedItem type="references" displayLabel="cit62"><titleInfo><title>Silicon‐based dendrimers.</title></titleInfo><name type="personal"><namePart type="given">H</namePart><namePart type="family">Frey</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C.</namePart><namePart type="family">Schlenk</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Frey H, Schlenk C. Silicon‐based dendrimers. Top Curr Chem 2000, 210:69–129.</note><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>210</number></detail><extent unit="pages"><start>69</start><end>129.</end></extent></part><relatedItem type="host"><titleInfo><title>Top Curr Chem</title></titleInfo><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>210</number></detail><extent unit="pages"><start>69</start><end>129.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit63"><titleInfo><title>Carbosilane dendrimrs.</title></titleInfo><name type="personal"><namePart type="given">J</namePart><namePart type="family">Roovers</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.</namePart><namePart type="family">Ding</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>book-chapter</genre><relatedItem type="host"><titleInfo><title>Advances in Silicone Science</title></titleInfo><originInfo><publisher>Springer</publisher><place><placeTerm type="text">Dordrecht</placeTerm></place></originInfo><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>2.</number></detail><extent unit="pages"><start>31</start><end>74.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit64"><titleInfo><title>Globular carbosilane dendrimers with mannose groups at the periphery: synthesis, characterization and toxicity in dendritic cells.</title></titleInfo><name type="personal"><namePart type="given">P</namePart><namePart type="family">Ortega</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Serramía</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Muñoz‐Fernández</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">FJ</namePart><namePart type="family">de la Mata</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R.</namePart><namePart type="family">Gómez</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Ortega P, Serramía J, Muñoz‐Fernández A, de la Mata FJ, Gómez R. Globular carbosilane dendrimers with mannose groups at the periphery: synthesis, characterization and toxicity in dendritic cells. Tetrahedron 2010, 66:3326–3331.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>66</number></detail><extent unit="pages"><start>3326</start><end>3331.</end></extent></part><relatedItem type="host"><titleInfo><title>Tetrahedron</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>66</number></detail><extent unit="pages"><start>3326</start><end>3331.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit65"><titleInfo><title>Carbosilane dendrimers NN8 and NN16 form a stable complex with siGAG1.</title></titleInfo><name type="personal"><namePart type="given">D</namePart><namePart type="family">Shcharbin</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E</namePart><namePart type="family">Pedziwiatr</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">O</namePart><namePart type="family">Nowacka</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Kumar</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Zaborski</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P</namePart><namePart type="family">Ortega</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">FJ</namePart><namePart type="family">de la Mata</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R</namePart><namePart type="family">Gómez</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MA</namePart><namePart type="family">Muñez‐Fernandez</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Bryszewska</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Shcharbin D, Pedziwiatr E, Nowacka O, Kumar M, Zaborski M, Ortega P, de la Mata FJ, Gómez R, Muñez‐Fernandez MA, Bryszewska M. Carbosilane dendrimers NN8 and NN16 form a stable complex with siGAG1. Colloids Surf B Biointerfaces 2011, 83:388–391.</note><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>83</number></detail><extent unit="pages"><start>388</start><end>391.</end></extent></part><relatedItem type="host"><titleInfo><title>Colloids Surf B Biointerfaces</title></titleInfo><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>83</number></detail><extent unit="pages"><start>388</start><end>391.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit66"><titleInfo><title>Characterization of carbosilane dendrimers as effective carriers of siRNA to HIV‐infected lymphocytes.</title></titleInfo><name type="personal"><namePart type="given">N</namePart><namePart type="family">Weber</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P</namePart><namePart type="family">Ortega</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MI</namePart><namePart type="family">Clemente</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D</namePart><namePart type="family">Shchlarbin</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Bryszewska</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">FJ</namePart><namePart type="family">de la Mata</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R</namePart><namePart type="family">Gómez</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MA.</namePart><namePart type="family">Muñez‐Fernandez</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Weber N, Ortega P, Clemente MI, Shchlarbin D, Bryszewska M, de la Mata FJ, Gómez R, Muñez‐Fernandez MA. Characterization of carbosilane dendrimers as effective carriers of siRNA to HIV‐infected lymphocytes. J Control Rel 2008, 132:55–64.</note><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>132</number></detail><extent unit="pages"><start>55</start><end>64.</end></extent></part><relatedItem type="host"><titleInfo><title>J Control Rel</title></titleInfo><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>132</number></detail><extent unit="pages"><start>55</start><end>64.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit67"><titleInfo><title>Water‐soluble phosphorus‐containing dendrimers.</title></titleInfo><name type="personal"><namePart type="given">AM</namePart><namePart type="family">Caminade</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JP.</namePart><namePart type="family">Majoral</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Caminade AM, Majoral JP. Water‐soluble phosphorus‐containing dendrimers. Prog Polym Sci 2005, 30:491–505.</note><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>30</number></detail><extent unit="pages"><start>491</start><end>505.</end></extent></part><relatedItem type="host"><titleInfo><title>Prog Polym Sci</title></titleInfo><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>30</number></detail><extent unit="pages"><start>491</start><end>505.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit68"><titleInfo><title>Surface, core, and structure modifications of phosphorus‐containing dendrimers. Influence on the thermal stability.</title></titleInfo><name type="personal"><namePart type="given">CO</namePart><namePart type="family">Turrin</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">V</namePart><namePart type="family">Maraval</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Leclaire</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E</namePart><namePart type="family">Dantras</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C</namePart><namePart type="family">Lacabanne</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AM</namePart><namePart type="family">Caminade</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JP.</namePart><namePart type="family">Majoral</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Turrin CO, Maraval V, Leclaire J, Dantras E, Lacabanne C, Caminade AM, Majoral JP. Surface, core, and structure modifications of phosphorus‐containing dendrimers. Influence on the thermal stability. Tetrahedron 2003, 59:3965–3973.</note><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>59</number></detail><extent unit="pages"><start>3965</start><end>3973.</end></extent></part><relatedItem type="host"><titleInfo><title>Tetrahedron</title></titleInfo><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>59</number></detail><extent unit="pages"><start>3965</start><end>3973.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit69"><titleInfo><title>Interaction of cationic phosphorus dendrimers (CPD) with charged and neutral lipid membranes.</title></titleInfo><name type="personal"><namePart type="given">M</namePart><namePart type="family">Ionov</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">K</namePart><namePart type="family">Gardikis</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D</namePart><namePart type="family">Wróbel</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Hatziantoniou</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H</namePart><namePart type="family">Mourelatou</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JP</namePart><namePart type="family">Majoral</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B</namePart><namePart type="family">Klajnert</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Bryszewska</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C.</namePart><namePart type="family">Demetzos</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Ionov M, Gardikis K, Wróbel D, Hatziantoniou S, Mourelatou H, Majoral JP, Klajnert B, Bryszewska M, Demetzos C. Interaction of cationic phosphorus dendrimers (CPD) with charged and neutral lipid membranes. Colloids Surf B Biointerfaces 2011, 82:8–12.</note><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>82</number></detail><extent unit="pages"><start>8</start><end>12.</end></extent></part><relatedItem type="host"><titleInfo><title>Colloids Surf B Biointerfaces</title></titleInfo><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>82</number></detail><extent unit="pages"><start>8</start><end>12.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit70"><titleInfo><title>Interactions of phosphorus‐containing dendrimers with liposomes.</title></titleInfo><name type="personal"><namePart type="given">D</namePart><namePart type="family">Wrobel</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Ionov</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">K</namePart><namePart type="family">Gardikis</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C</namePart><namePart type="family">Demetzos</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JP</namePart><namePart type="family">Majoral</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B</namePart><namePart type="family">Palecz</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B</namePart><namePart type="family">Klajnert</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Bryszewska</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Wrobel D, Ionov M, Gardikis K, Demetzos C, Majoral JP, Palecz B, Klajnert B, Bryszewska M. Interactions of phosphorus‐containing dendrimers with liposomes. Biochim Biophys Acta 2011, 1811:221–226.</note><part><date>2011</date><extent unit="pages"><start>221</start><end>226.</end></extent></part><relatedItem type="host"><titleInfo><title>Biochim Biophys Acta</title></titleInfo><part><date>2011</date><extent unit="pages"><start>221</start><end>226.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit71"><titleInfo><title>Polycationic phosphorus dendrimers: synthesis, characterization, study of cytotoxicity, complexation of DNA, and transfection experiments.</title></titleInfo><name type="personal"><namePart type="given">C</namePart><namePart type="family">Padié</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Maszewska</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">K</namePart><namePart type="family">Majchrzak</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B</namePart><namePart type="family">Nawrot</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AM</namePart><namePart type="family">Caminade</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JP.</namePart><namePart type="family">Majoral</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Padié C, Maszewska M, Majchrzak K, Nawrot B, Caminade AM, Majoral JP. Polycationic phosphorus dendrimers: synthesis, characterization, study of cytotoxicity, complexation of DNA, and transfection experiments. New J Chem 2009, 33:318–326.</note><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>33</number></detail><extent unit="pages"><start>318</start><end>326.</end></extent></part><relatedItem type="host"><titleInfo><title>New J Chem</title></titleInfo><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>33</number></detail><extent unit="pages"><start>318</start><end>326.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit72"><titleInfo><title>Neurons and stromal stem cells as targets for polycation‐mediated transfection.</title></titleInfo><name type="personal"><namePart type="given">AV</namePart><namePart type="family">Shakhbazau</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">DG</namePart><namePart type="family">Shcharbin</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">NV</namePart><namePart type="family">Goncharova</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">IN</namePart><namePart type="family">Seviaryn</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">SM</namePart><namePart type="family">Kosnacheva</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">NA</namePart><namePart type="family">Kartel</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Bryszewska</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JP</namePart><namePart type="family">Majoral</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MP.</namePart><namePart type="family">Potapnev</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Shakhbazau AV, Shcharbin DG, Goncharova NV, Seviaryn IN, Kosnacheva SM, Kartel NA, Bryszewska M, Majoral JP, Potapnev MP. Neurons and stromal stem cells as targets for polycation‐mediated transfection. Bull Exp Biol Med 2011, 151:126–129.</note><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>151</number></detail><extent unit="pages"><start>126</start><end>129.</end></extent></part><relatedItem type="host"><titleInfo><title>Bull Exp Biol Med</title></titleInfo><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>151</number></detail><extent unit="pages"><start>126</start><end>129.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit73"><titleInfo><title>Time evolution of aggregation process of peptides involved in neurodegenerative diseases and preventing aggregation effect of phosphorus dendrimers studied by EPR.</title></titleInfo><name type="personal"><namePart type="given">MF</namePart><namePart type="family">Ottaviani</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R</namePart><namePart type="family">Mazzeo</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Cangiotti</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">L</namePart><namePart type="family">Fiorani</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JP</namePart><namePart type="family">Majoral</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AM</namePart><namePart type="family">Caminade</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E</namePart><namePart type="family">Pedziwiatr</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Bryszewska</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B.</namePart><namePart type="family">Klajnert</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Ottaviani MF, Mazzeo R, Cangiotti M, Fiorani L, Majoral JP, Caminade AM, Pedziwiatr E, Bryszewska M, Klajnert B. Time evolution of aggregation process of peptides involved in neurodegenerative diseases and preventing aggregation effect of phosphorus dendrimers studied by EPR. Biomacromolecules 2010, 11:3014–3021.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>11</number></detail><extent unit="pages"><start>3014</start><end>3021.</end></extent></part><relatedItem type="host"><titleInfo><title>Biomacromolecules</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>11</number></detail><extent unit="pages"><start>3014</start><end>3021.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit74"><titleInfo><title>Designing dendrimers for ocular drug delivery.</title></titleInfo><name type="personal"><namePart type="given">G</namePart><namePart type="family">Spataro</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F</namePart><namePart type="family">Malecaze</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">CO</namePart><namePart type="family">Turrin</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">V</namePart><namePart type="family">Soler</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C</namePart><namePart type="family">Duhayon</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">PP</namePart><namePart type="family">Elena</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JP</namePart><namePart type="family">Majoral</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AM.</namePart><namePart type="family">Caminade</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Spataro G, Malecaze F, Turrin CO, Soler V, Duhayon C, Elena PP, Majoral JP, Caminade AM. Designing dendrimers for ocular drug delivery. Eur J Med Chem 2010, 45:326–334.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>45</number></detail><extent unit="pages"><start>326</start><end>334.</end></extent></part><relatedItem type="host"><titleInfo><title>Eur J Med Chem</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>45</number></detail><extent unit="pages"><start>326</start><end>334.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit75"><titleInfo><title>Brilliant organic nanodots: novel nano‐objects for bionanophotonics.</title></titleInfo><name type="personal"><namePart type="given">O</namePart><namePart type="family">Mongin</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C</namePart><namePart type="family">Rouxel</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AC</namePart><namePart type="family">Robin</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Pla‐Quintana</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">TR</namePart><namePart type="family">Krishna</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G</namePart><namePart type="family">Recher</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F</namePart><namePart type="family">Tiaho</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AM</namePart><namePart type="family">Caminade</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JP</namePart><namePart type="family">Majoral</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Blanchard‐Desce</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Mongin O, Rouxel C, Robin AC, Pla‐Quintana A, Krishna TR, Recher G, Tiaho F, Caminade AM, Majoral JP, Blanchard‐Desce M. Brilliant organic nanodots: novel nano‐objects for bionanophotonics. Proc SPIE‐Int Soc Opt Eng 2008, 7040:704006.</note><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>7040</number></detail><extent unit="pages"><start>704006.</start></extent></part><relatedItem type="host"><titleInfo><title>Proc SPIE‐Int Soc Opt Eng</title></titleInfo><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>7040</number></detail><extent unit="pages"><start>704006.</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit76"><titleInfo><title>Cationic phosphorus‐containing dendrimers reduce prion replication both in cell culture and in mice infected with scrapie.</title></titleInfo><name type="personal"><namePart type="given">J</namePart><namePart type="family">Solassol</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C</namePart><namePart type="family">Crozet</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">V</namePart><namePart type="family">Perrier</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Leclaire</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F</namePart><namePart type="family">Béranger</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AM</namePart><namePart type="family">Caminade</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B</namePart><namePart type="family">Meunier</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D</namePart><namePart type="family">Dormont</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JP</namePart><namePart type="family">Majoral</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.</namePart><namePart type="family">Lehmann</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Solassol J, Crozet C, Perrier V, Leclaire J, Béranger F, Caminade AM, Meunier B, Dormont D, Majoral JP, Lehmann S. Cationic phosphorus‐containing dendrimers reduce prion replication both in cell culture and in mice infected with scrapie. J Gen Virol 2004, 85:791–799.</note><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>85</number></detail><extent unit="pages"><start>791</start><end>799.</end></extent></part><relatedItem type="host"><titleInfo><title>J Gen Virol</title></titleInfo><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>85</number></detail><extent unit="pages"><start>791</start><end>799.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit77"><titleInfo><title>Seasonal influenza vaccines.</title></titleInfo><name type="personal"><namePart type="given">AR</namePart><namePart type="family">Fiore</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">CB</namePart><namePart type="family">Bridges</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">NJ.</namePart><namePart type="family">Cox</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Fiore AR, Bridges CB, Cox NJ. Seasonal influenza vaccines. Curr Top Microbiol Immunol 2009, 333:43–82.</note><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>333</number></detail><extent unit="pages"><start>43</start><end>82.</end></extent></part><relatedItem type="host"><titleInfo><title>Curr Top Microbiol Immunol</title></titleInfo><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>333</number></detail><extent unit="pages"><start>43</start><end>82.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit78"><titleInfo><title>Influenza hemagglutinin and neuraminidase membrane glycoproteins.</title></titleInfo><name type="personal"><namePart type="given">SJ</namePart><namePart type="family">Gamblin</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JJ.</namePart><namePart type="family">Skehel</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Gamblin SJ, Skehel JJ. Influenza hemagglutinin and neuraminidase membrane glycoproteins. J Biol Chem 2010, 285:28403–28409.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>285</number></detail><extent unit="pages"><start>28403</start><end>28409.</end></extent></part><relatedItem type="host"><titleInfo><title>J Biol Chem</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>285</number></detail><extent unit="pages"><start>28403</start><end>28409.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit79"><titleInfo><title>Drugs for chemotherapy and prophylaxis of influenza: mechanisms, efficacy, and safety.</title></titleInfo><name type="personal"><namePart type="given">IA</namePart><namePart type="family">Leneva</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RG</namePart><namePart type="family">Glushkov</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">TA.</namePart><namePart type="family">Gus'kova</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Leneva IA, Glushkov RG, Gus'kova TA. Drugs for chemotherapy and prophylaxis of influenza: mechanisms, efficacy, and safety. Pharm Chem J 2004, 38:8–14.</note><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>38</number></detail><extent unit="pages"><start>8</start><end>14.</end></extent></part><relatedItem type="host"><titleInfo><title>Pharm Chem J</title></titleInfo><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>38</number></detail><extent unit="pages"><start>8</start><end>14.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit80"><titleInfo><title>Recent advances in the synthesis of sialic acid derivatives and sialylmimetics as biological probes.</title></titleInfo><name type="personal"><namePart type="given">MJ</namePart><namePart type="family">Kiefel</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.</namePart><namePart type="family">von Itzstein</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Kiefel MJ, von Itzstein M. Recent advances in the synthesis of sialic acid derivatives and sialylmimetics as biological probes. Chem Rev 2002, 102:471–490.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>102</number></detail><extent unit="pages"><start>471</start><end>490.</end></extent></part><relatedItem type="host"><titleInfo><title>Chem Rev</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>102</number></detail><extent unit="pages"><start>471</start><end>490.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit81"><titleInfo><title>An O‐glycoside of sialic acid derivative that inhibits both hemagglutinin and sialidase activities of influenza viruses.</title></titleInfo><name type="personal"><namePart type="given">CT</namePart><namePart type="family">Guo</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">X‐L</namePart><namePart type="family">Sun</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">O</namePart><namePart type="family">Kanie</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">KF</namePart><namePart type="family">Shortridge</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T</namePart><namePart type="family">Suzuki</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D</namePart><namePart type="family">Miyamoto</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">KI‐P</namePart><namePart type="family">Jwa Hidari</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C‐H</namePart><namePart type="family">Wong</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Y.</namePart><namePart type="family">Suzuki</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Guo CT, Sun X‐L, Kanie O, Shortridge KF, Suzuki T, Miyamoto D, Jwa Hidari KI‐P, Wong C‐H, Suzuki Y. An O‐glycoside of sialic acid derivative that inhibits both hemagglutinin and sialidase activities of influenza viruses. Glycobiology 2002, 12:183–190.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>12</number></detail><extent unit="pages"><start>183</start><end>190.</end></extent></part><relatedItem type="host"><titleInfo><title>Glycobiology</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>12</number></detail><extent unit="pages"><start>183</start><end>190.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit82"><titleInfo><title>Filovirus emergence and vaccine development: a perspective for health care practitioners in travel medicine.</title></titleInfo><name type="personal"><namePart type="given">UN</namePart><namePart type="family">Sarwar</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Sitar</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JE.</namePart><namePart type="family">Ledgerwood</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Sarwar UN, Sitar S, Ledgerwood JE. Filovirus emergence and vaccine development: a perspective for health care practitioners in travel medicine. Travel Med Infect Dis 2011, 9:126–134.</note><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>9</number></detail><extent unit="pages"><start>126</start><end>134.</end></extent></part><relatedItem type="host"><titleInfo><title>Travel Med Infect Dis</title></titleInfo><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>9</number></detail><extent unit="pages"><start>126</start><end>134.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit83"><titleInfo><title>Ebola haemorrhagic fever.</title></titleInfo><name type="personal"><namePart type="given">H</namePart><namePart type="family">Feldmann</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">TW.</namePart><namePart type="family">Geisbert</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Feldmann H, Geisbert TW. Ebola haemorrhagic fever. Lancet 2011, 377:849–862.</note><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>377</number></detail><extent unit="pages"><start>849</start><end>862.</end></extent></part><relatedItem type="host"><titleInfo><title>Lancet</title></titleInfo><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>377</number></detail><extent unit="pages"><start>849</start><end>862.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit84"><titleInfo><title>DC‐SIGN and DC‐SIGNR bind Ebola glycoproteins and enhance infection of macrophages and endothelial cells.</title></titleInfo><name type="personal"><namePart type="given">G</namePart><namePart type="family">Simmons</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JD</namePart><namePart type="family">Reeves</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">CC</namePart><namePart type="family">Grogan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">LH</namePart><namePart type="family">Vandenberghe</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F</namePart><namePart type="family">Baribaud</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JC</namePart><namePart type="family">Whitbeck</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E</namePart><namePart type="family">Burke</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MJ</namePart><namePart type="family">Buchmeier</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">EJ</namePart><namePart type="family">Soilleux</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JL</namePart><namePart type="family">Riley</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Simmons G, Reeves JD, Grogan CC, Vandenberghe LH, Baribaud F, Whitbeck JC, Burke E, Buchmeier MJ, Soilleux EJ, Riley JL, et al. DC‐SIGN and DC‐SIGNR bind Ebola glycoproteins and enhance infection of macrophages and endothelial cells. Virology 2003, 305:115–123.</note><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>305</number></detail><extent unit="pages"><start>115</start><end>123.</end></extent></part><relatedItem type="host"><titleInfo><title>Virology</title></titleInfo><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>305</number></detail><extent unit="pages"><start>115</start><end>123.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit85"><titleInfo><title>Pseudosaccharide functionalized dendrimers as potent inhibitors of DC‐SIGN dependent Ebola pseudotyped viral infection.</title></titleInfo><name type="personal"><namePart type="given">J</namePart><namePart type="family">Luczkowiak</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Sattin</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">I</namePart><namePart type="family">Sutkevičiūtė</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JJ</namePart><namePart type="family">Reina</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Sánchez‐Navarro</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Thépaut</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">L</namePart><namePart type="family">Martínez‐Prats</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Daghetti</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F</namePart><namePart type="family">Fieschi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R</namePart><namePart type="family">Delgado</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Luczkowiak J, Sattin S, Sutkevičiūtė I, Reina JJ, Sánchez‐Navarro M, Thépaut M, Martínez‐Prats L, Daghetti A, Fieschi F, Delgado R, et al. Pseudosaccharide functionalized dendrimers as potent inhibitors of DC‐SIGN dependent Ebola pseudotyped viral infection. Bioconjugate Chem 2011, 22:1354–1365.</note><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>22</number></detail><extent unit="pages"><start>1354</start><end>1365.</end></extent></part><relatedItem type="host"><titleInfo><title>Bioconjugate Chem</title></titleInfo><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>22</number></detail><extent unit="pages"><start>1354</start><end>1365.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit86"><titleInfo><title>Herpes simplex viruses: is a vaccine tenable?</title></titleInfo><name type="personal"><namePart type="given">RJ</namePart><namePart type="family">Whitley</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B.</namePart><namePart type="family">Roizman</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Whitley RJ, Roizman B. Herpes simplex viruses: is a vaccine tenable? J Clin Invest 2002, 110:145–151.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>110</number></detail><extent unit="pages"><start>145</start><end>151.</end></extent></part><relatedItem type="host"><titleInfo><title>J Clin Invest</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>110</number></detail><extent unit="pages"><start>145</start><end>151.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit87"><titleInfo><title>Slipping and sliding: frameshift mutations in herpes simplex virus thymidine kinase and drug‐resistance.</title></titleInfo><name type="personal"><namePart type="given">A.</namePart><namePart type="family">Griffiths</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Griffiths A. Slipping and sliding: frameshift mutations in herpes simplex virus thymidine kinase and drug‐resistance. Drug Resistance Updates 2011, 14:251–259.</note><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>14</number></detail><extent unit="pages"><start>251</start><end>259.</end></extent></part><relatedItem type="host"><titleInfo><title>Drug Resistance Updates</title></titleInfo><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>14</number></detail><extent unit="pages"><start>251</start><end>259.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit88"><titleInfo><title>van Hal SJ, Dwyer DE. Herpes Simplex: Viruses and Infections. Chichester: eLS; 2009.</title></titleInfo><note type="citation/reference">van Hal SJ, Dwyer DE. Herpes Simplex: Viruses and Infections. Chichester: eLS; 2009.</note><name type="personal"><namePart type="given">SJ</namePart><namePart type="family">van Hal</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">DE.</namePart><namePart type="family">Dwyer</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>book</genre><originInfo><publisher>eLS</publisher><place><placeTerm type="text">Chichester</placeTerm></place></originInfo><part><date>2009</date></part></relatedItem><relatedItem type="references" displayLabel="cit89"><titleInfo><title>Evaluations of unformulated and formulated dendrimer‐based microbicide candidates in mouse and guinea pig models of genital herpes.</title></titleInfo><name type="personal"><namePart type="given">DI</namePart><namePart type="family">Bernstein</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">LR</namePart><namePart type="family">Stanberry</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Sacks</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">NK</namePart><namePart type="family">Ayisi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">YH</namePart><namePart type="family">Gong</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Ireland</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RJ</namePart><namePart type="family">Mumper</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G</namePart><namePart type="family">Holan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B</namePart><namePart type="family">Matthews</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T</namePart><namePart type="family">McCarthy</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Bernstein DI, Stanberry LR, Sacks S, Ayisi NK, Gong YH, Ireland J, Mumper RJ, Holan G, Matthews B, McCarthy T, et al. Evaluations of unformulated and formulated dendrimer‐based microbicide candidates in mouse and guinea pig models of genital herpes. Antimicrob Agents Chemother 2003, 47:784–788.</note><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>47</number></detail><extent unit="pages"><start>784</start><end>788.</end></extent></part><relatedItem type="host"><titleInfo><title>Antimicrob Agents Chemother</title></titleInfo><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>47</number></detail><extent unit="pages"><start>784</start><end>788.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit90"><titleInfo><title>UNAIDS, Joint United Nations Programme on HIV/AIDS (UNAIDS), Report on the global AIDS epidemic, 2010.</title></titleInfo><name type="corporate"><namePart>UNAIDS</namePart></name><genre>other</genre><part><date>2010</date></part></relatedItem><relatedItem type="references" displayLabel="cit91"><titleInfo><title>Human immunodeficiency virus type 1 long‐term non‐progressors: the viral, genetic and immunological basis for disease non‐progression.</title></titleInfo><name type="personal"><namePart type="given">K</namePart><namePart type="family">Poropatich</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">DJ.</namePart><namePart type="family">Sullivan Jr</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Poropatich K, Sullivan Jr DJ. Human immunodeficiency virus type 1 long‐term non‐progressors: the viral, genetic and immunological basis for disease non‐progression. J Gen Virol 2011, 92:247–268.</note><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>92</number></detail><extent unit="pages"><start>247</start><end>268.</end></extent></part><relatedItem type="host"><titleInfo><title>J Gen Virol</title></titleInfo><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>92</number></detail><extent unit="pages"><start>247</start><end>268.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit92"><titleInfo><title>Distribution and lateral mobility of DC‐SIGN on immature dendritic cells—implications for pathogen uptake.</title></titleInfo><name type="personal"><namePart type="given">AK</namePart><namePart type="family">Neumann</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">NL</namePart><namePart type="family">Thompson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">K.</namePart><namePart type="family">Jacobson</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Neumann AK, Thompson NL, Jacobson K. Distribution and lateral mobility of DC‐SIGN on immature dendritic cells—implications for pathogen uptake. J Cell Sci 2008, 121:634–643.</note><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>121</number></detail><extent unit="pages"><start>634</start><end>643.</end></extent></part><relatedItem type="host"><titleInfo><title>J Cell Sci</title></titleInfo><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>121</number></detail><extent unit="pages"><start>634</start><end>643.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit93"><titleInfo><title>HIV‐1 coreceptors and their inhibitors.</title></titleInfo><name type="personal"><namePart type="given">N</namePart><namePart type="family">Ray</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R.</namePart><namePart type="family">Doms</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Ray N, Doms R. HIV‐1 coreceptors and their inhibitors. Curr Top Microbiol Immunol 2006, 303:97–120.</note><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>303</number></detail><extent unit="pages"><start>97</start><end>120.</end></extent></part><relatedItem type="host"><titleInfo><title>Curr Top Microbiol Immunol</title></titleInfo><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>303</number></detail><extent unit="pages"><start>97</start><end>120.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit94"><titleInfo><title>A V3 loop‐dependent gp120 element disrupted by CD4 binding stabilizes the human immunodeficiency virus envelope glycoprotein trime.</title></titleInfo><name type="personal"><namePart type="given">SH</namePart><namePart type="family">Xiang</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Finzi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B</namePart><namePart type="family">Pacheco</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">K</namePart><namePart type="family">Alexander</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">W</namePart><namePart type="family">Yuan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C</namePart><namePart type="family">Rizzuto</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">CC</namePart><namePart type="family">Huang</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">PD</namePart><namePart type="family">Kwong</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.</namePart><namePart type="family">Sodroski</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Xiang SH, Finzi A, Pacheco B, Alexander K, Yuan W, Rizzuto C, Huang CC, Kwong PD, Sodroski J. A V3 loop‐dependent gp120 element disrupted by CD4 binding stabilizes the human immunodeficiency virus envelope glycoprotein trime. J Virol 2010, 84:3147–3161.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>84</number></detail><extent unit="pages"><start>3147</start><end>3161.</end></extent></part><relatedItem type="host"><titleInfo><title>J Virol</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>84</number></detail><extent unit="pages"><start>3147</start><end>3161.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit95"><titleInfo><title>Phosphonate terminated PPH dendrimers: influence of pendant alkyl chains on the in vitro anti‐HIV‐1 properties.</title></titleInfo><name type="personal"><namePart type="given">A</namePart><namePart type="family">Pérez‐Anes</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G</namePart><namePart type="family">Spataro</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Y</namePart><namePart type="family">Coppel</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C</namePart><namePart type="family">Moog</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Blanzant</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">CO</namePart><namePart type="family">Turrin</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AM</namePart><namePart type="family">Caminade</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">I</namePart><namePart type="family">Rico‐Lattes</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JP.</namePart><namePart type="family">Majoral</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Pérez‐Anes A, Spataro G, Coppel Y, Moog C, Blanzant M, Turrin CO, Caminade AM, Rico‐Lattes I, Majoral JP. Phosphonate terminated PPH dendrimers: influence of pendant alkyl chains on the in vitro anti‐HIV‐1 properties. Org Biomol Chem 2009, 7:3491–3498.</note><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>7</number></detail><extent unit="pages"><start>3491</start><end>3498.</end></extent></part><relatedItem type="host"><titleInfo><title>Org Biomol Chem</title></titleInfo><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>7</number></detail><extent unit="pages"><start>3491</start><end>3498.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit96"><titleInfo><title>Multivalent catanionic GalCer analogs derived from first generation dendrimeric phosphonic acids.</title></titleInfo><name type="personal"><namePart type="given">A</namePart><namePart type="family">Pérez‐Anes</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C</namePart><namePart type="family">Stefaniu</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C</namePart><namePart type="family">Moog</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JP</namePart><namePart type="family">Majoral</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Blanzat</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">CO</namePart><namePart type="family">Turrin</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AM</namePart><namePart type="family">Caminade</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">I.</namePart><namePart type="family">IRico‐Lattes</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Pérez‐Anes A, Stefaniu C, Moog C, Majoral JP, Blanzat M, Turrin CO, Caminade AM, IRico‐Lattes I. Multivalent catanionic GalCer analogs derived from first generation dendrimeric phosphonic acids. Bioorg Med Chem 2010, 18:242–248.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>18</number></detail><extent unit="pages"><start>242</start><end>248.</end></extent></part><relatedItem type="host"><titleInfo><title>Bioorg Med Chem</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>18</number></detail><extent unit="pages"><start>242</start><end>248.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit97"><titleInfo><title>Sulfated oligosaccharide cluster with polylysine core scaffold as a new anti‐HIV dendrimer.</title></titleInfo><name type="personal"><namePart type="given">S</namePart><namePart type="family">Han</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D</namePart><namePart type="family">Yoshida</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T</namePart><namePart type="family">Kanamoto</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H</namePart><namePart type="family">Nakashima</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T</namePart><namePart type="family">Uryu</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T.</namePart><namePart type="family">Yoshida</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Han S, Yoshida D, Kanamoto T, Nakashima H, Uryu T, Yoshida T. Sulfated oligosaccharide cluster with polylysine core scaffold as a new anti‐HIV dendrimer. Carbohydr Polym 2010, 80:1111–1115.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>80</number></detail><extent unit="pages"><start>1111</start><end>1115.</end></extent></part><relatedItem type="host"><titleInfo><title>Carbohydr Polym</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>80</number></detail><extent unit="pages"><start>1111</start><end>1115.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit98"><titleInfo><title>Papillomavirus prophylactic vaccines: established successes, new approaches.</title></titleInfo><name type="personal"><namePart type="given">MS</namePart><namePart type="family">Campo</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RBS.</namePart><namePart type="family">Roden</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Campo MS, Roden RBS. Papillomavirus prophylactic vaccines: established successes, new approaches. J Virol 2010, 84:1214–1220.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>84</number></detail><extent unit="pages"><start>1214</start><end>1220.</end></extent></part><relatedItem type="host"><titleInfo><title>J Virol</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>84</number></detail><extent unit="pages"><start>1214</start><end>1220.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit99"><titleInfo><title>Immunobiology of human cytomegalovirus: from bench to bedside.</title></titleInfo><name type="personal"><namePart type="given">T</namePart><namePart type="family">Crough</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R.</namePart><namePart type="family">Khanna</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Crough T, Khanna R. Immunobiology of human cytomegalovirus: from bench to bedside. Clin Microbiol Rev 2009, 22:76–98.</note><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>22</number></detail><extent unit="pages"><start>76</start><end>98.</end></extent></part><relatedItem type="host"><titleInfo><title>Clin Microbiol Rev</title></titleInfo><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>22</number></detail><extent unit="pages"><start>76</start><end>98.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit100"><titleInfo><title>Early inhibitors of human cytomegalovirus: state‐of‐art and therapeutic perspectives.</title></titleInfo><name type="personal"><namePart type="given">B</namePart><namePart type="family">Mercorelli</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D</namePart><namePart type="family">Lembo</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G</namePart><namePart type="family">Palú</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A.</namePart><namePart type="family">Loregian</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Mercorelli B, Lembo D, Palú G, Loregian A. Early inhibitors of human cytomegalovirus: state‐of‐art and therapeutic perspectives. Pharmacol Ther 2011, 131:309–329.</note><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>131</number></detail><extent unit="pages"><start>309</start><end>329</end></extent></part><relatedItem type="host"><titleInfo><title>Pharmacol Ther</title></titleInfo><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>131</number></detail><extent unit="pages"><start>309</start><end>329</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit101"><titleInfo><title>How does cellular heparan sulfate function in viral pathogenicity?</title></titleInfo><name type="personal"><namePart type="given">W</namePart><namePart type="family">Zhu</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Li</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G.</namePart><namePart type="family">Liang</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Zhu W, Li J, Liang G. How does cellular heparan sulfate function in viral pathogenicity? Biomed Environ Sci 2011, 24:81–87.</note><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>24</number></detail><extent unit="pages"><start>81</start><end>87.</end></extent></part><relatedItem type="host"><titleInfo><title>Biomed Environ Sci</title></titleInfo><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>24</number></detail><extent unit="pages"><start>81</start><end>87.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit102"><titleInfo><title>Entry of human cytomegalovirus into retinal pigment epithelial and endothelial cells by endocytosis.</title></titleInfo><name type="personal"><namePart type="given">B</namePart><namePart type="family">Bodaghi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MEP</namePart><namePart type="family">Slobbe‐van Drunen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Topilko</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E</namePart><namePart type="family">Perret</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RCRM</namePart><namePart type="family">Vossen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MCE</namePart><namePart type="family">van Dam‐Mieras</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D</namePart><namePart type="family">Zipeto</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JL</namePart><namePart type="family">Virelizier</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P</namePart><namePart type="family">LeHoang</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">CA</namePart><namePart type="family">Bruggeman</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.</namePart><namePart type="family">Michelson</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Bodaghi B, Slobbe‐van Drunen MEP, Topilko A, Perret E, Vossen RCRM, van Dam‐Mieras MCE, Zipeto D, Virelizier JL, LeHoang P, Bruggeman CA, Michelson S. Entry of human cytomegalovirus into retinal pigment epithelial and endothelial cells by endocytosis. Invest Ophthalmol Vis Sci 1999, 40:2598–2607.</note><part><date>1999</date><detail type="volume"><caption>vol.</caption><number>40</number></detail><extent unit="pages"><start>2598</start><end>2607.</end></extent></part><relatedItem type="host"><titleInfo><title>Invest Ophthalmol Vis Sci</title></titleInfo><part><date>1999</date><detail type="volume"><caption>vol.</caption><number>40</number></detail><extent unit="pages"><start>2598</start><end>2607.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit103"><titleInfo><title>Mechanisms of cell entry by human papillomaviruses: an overview.</title></titleInfo><name type="personal"><namePart type="given">CAJ</namePart><namePart type="family">Horvath</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">GAV</namePart><namePart type="family">Boulet</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">VM</namePart><namePart type="family">Renoux</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">PO</namePart><namePart type="family">Delvenne</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JPJ.</namePart><namePart type="family">Bogers</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Horvath CAJ, Boulet GAV, Renoux VM, Delvenne PO, Bogers JPJ. Mechanisms of cell entry by human papillomaviruses: an overview. Virol J 2010, 7:11.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>7</number></detail><extent unit="pages"><start>11.</start></extent></part><relatedItem type="host"><titleInfo><title>Virol J</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>7</number></detail><extent unit="pages"><start>11.</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit104"><titleInfo><title>The global need for effective antibiotics‐moving towards concerted action.</title></titleInfo><name type="personal"><namePart type="given">O</namePart><namePart type="family">Cars</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Hedin</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A.</namePart><namePart type="family">Heddini</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Cars O, Hedin A, Heddini A. The global need for effective antibiotics‐moving towards concerted action. Drug Resist Updates 2011, 14:68–69.</note><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>14</number></detail><extent unit="pages"><start>68</start><end>69.</end></extent></part><relatedItem type="host"><titleInfo><title>Drug Resist Updates</title></titleInfo><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>14</number></detail><extent unit="pages"><start>68</start><end>69.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit105"><titleInfo><title>Unmet medical needs in antibacterial therapy.</title></titleInfo><name type="personal"><namePart type="given">LB.</namePart><namePart type="family">Rice</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Rice LB. Unmet medical needs in antibacterial therapy. Biochem Pharmacol 2006, 71:991–995.</note><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>71</number></detail><extent unit="pages"><start>991</start><end>995</end></extent></part><relatedItem type="host"><titleInfo><title>Biochem Pharmacol</title></titleInfo><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>71</number></detail><extent unit="pages"><start>991</start><end>995</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit106"><titleInfo><title>Assessment of linezolid resistance mechanisms among Staphylococcus epidermidis causing bacteraemia in Rome, Italy.</title></titleInfo><name type="personal"><namePart type="given">RE</namePart><namePart type="family">Mendes</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">LM</namePart><namePart type="family">Deshpande</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">DJ</namePart><namePart type="family">Farrell</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T</namePart><namePart type="family">Spanu</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G</namePart><namePart type="family">Fadda</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RN.</namePart><namePart type="family">Jones</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Mendes RE, Deshpande LM, Farrell DJ, Spanu T, Fadda G, Jones RN. Assessment of linezolid resistance mechanisms among Staphylococcus epidermidis causing bacteraemia in Rome, Italy. J Antimicrob Chemother 2010, 65:2329–2335.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>65</number></detail><extent unit="pages"><start>2329</start><end>2335.</end></extent></part><relatedItem type="host"><titleInfo><title>J Antimicrob Chemother</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>65</number></detail><extent unit="pages"><start>2329</start><end>2335.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit107"><titleInfo><title>Design of antimicrobially active small amphiphilic peptide dendrimers.</title></titleInfo><name type="personal"><namePart type="given">P</namePart><namePart type="family">Polcyn</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Jurczak</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Rajnisz</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Solecka</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Z.</namePart><namePart type="family">Urbanczyk‐Lipowska</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Polcyn P, Jurczak M, Rajnisz A, Solecka J, Urbanczyk‐Lipowska Z. Design of antimicrobially active small amphiphilic peptide dendrimers. Molecules 2009, 14:3881–3905.</note><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>14</number></detail><extent unit="pages"><start>3881</start><end>3905.</end></extent></part><relatedItem type="host"><titleInfo><title>Molecules</title></titleInfo><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>14</number></detail><extent unit="pages"><start>3881</start><end>3905.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit108"><titleInfo><title>Antimicrobial dendrimeric peptides.</title></titleInfo><name type="personal"><namePart type="given">JP</namePart><namePart type="family">Tam</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">YA</namePart><namePart type="family">Lu</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JL.</namePart><namePart type="family">Yang</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Tam JP, Lu YA, Yang JL. Antimicrobial dendrimeric peptides. Eur J Biochem 2002, 269:923–932.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>269</number></detail><extent unit="pages"><start>923</start><end>932.</end></extent></part><relatedItem type="host"><titleInfo><title>Eur J Biochem</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>269</number></detail><extent unit="pages"><start>923</start><end>932.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit109"><titleInfo><title>Tuning the membrane selectivity of antimicrobial peptides by using multivalent design.</title></titleInfo><name type="personal"><namePart type="given">Z</namePart><namePart type="family">Liu</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AW</namePart><namePart type="family">Young</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P</namePart><namePart type="family">Hu</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AJ</namePart><namePart type="family">Rice</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C</namePart><namePart type="family">Zhou</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Y</namePart><namePart type="family">Zhang</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">NR.</namePart><namePart type="family">Kallenbach</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Liu Z, Young AW, Hu P, Rice AJ, Zhou C, Zhang Y, Kallenbach NR. Tuning the membrane selectivity of antimicrobial peptides by using multivalent design. ChemBioChem 2007, 8:2063–2065.</note><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>8</number></detail><extent unit="pages"><start>2063</start><end>2065.</end></extent></part><relatedItem type="host"><titleInfo><title>ChemBioChem</title></titleInfo><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>8</number></detail><extent unit="pages"><start>2063</start><end>2065.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit110"><titleInfo><title>Antimicrobial dendrimer active against Escherichia coli biofilms.</title></titleInfo><name type="personal"><namePart type="given">S</namePart><namePart type="family">Hou</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C</namePart><namePart type="family">Zhou</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Z</namePart><namePart type="family">Liu</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AW</namePart><namePart type="family">Youn</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Z</namePart><namePart type="family">Shi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D</namePart><namePart type="family">Ren</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">NR.</namePart><namePart type="family">Kallenbach</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Hou S, Zhou C, Liu Z, Youn AW, Shi Z, Ren D, Kallenbach NR. Antimicrobial dendrimer active against Escherichia coli biofilms. Bioorg Med Chem Lett 2009, 19:5478–5481.</note><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>19</number></detail><extent unit="pages"><start>5478</start><end>5481.</end></extent></part><relatedItem type="host"><titleInfo><title>Bioorg Med Chem Lett</title></titleInfo><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>19</number></detail><extent unit="pages"><start>5478</start><end>5481.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit111"><titleInfo><title>Biofunctionalization of silicone polymers using poly(amidoamine) dendrimers and a mannose derivative for prolonged interference against pathogen colonization.</title></titleInfo><name type="personal"><namePart type="given">AI</namePart><namePart type="family">Lopez</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Kumar</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MR</namePart><namePart type="family">Planas</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Y</namePart><namePart type="family">Li</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">TV</namePart><namePart type="family">Nguyen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C.</namePart><namePart type="family">Cai</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Lopez AI, Kumar A, Planas MR, Li Y, Nguyen TV, Cai C. Biofunctionalization of silicone polymers using poly(amidoamine) dendrimers and a mannose derivative for prolonged interference against pathogen colonization. Biomaterials 2011, 32:4336–4346.</note><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>32</number></detail><extent unit="pages"><start>4336</start><end>4346.</end></extent></part><relatedItem type="host"><titleInfo><title>Biomaterials</title></titleInfo><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>32</number></detail><extent unit="pages"><start>4336</start><end>4346.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit112"><titleInfo><title>Inhibition and dispersion of Pseudomonas aeruginosa biofilms by glycopeptide dendrimers targeting the fucose‐specific lectin LecB.</title></titleInfo><name type="personal"><namePart type="given">EMV</namePart><namePart type="family">Johansson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">SA</namePart><namePart type="family">Crusz</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E</namePart><namePart type="family">Kolomiets</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">L</namePart><namePart type="family">Buts</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RU</namePart><namePart type="family">Kadam</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Cacciarini</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">KM</namePart><namePart type="family">Barteles</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">SP</namePart><namePart type="family">Diggle</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Cámara</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P</namePart><namePart type="family">Williams</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R</namePart><namePart type="family">Loris</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C</namePart><namePart type="family">Nativi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F</namePart><namePart type="family">Rosenau</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">KE</namePart><namePart type="family">Jaeger</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T</namePart><namePart type="family">Darbre</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JL.</namePart><namePart type="family">Reymond</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Johansson EMV, Crusz SA, Kolomiets E, Buts L, Kadam RU, Cacciarini M, Barteles KM, Diggle SP, Cámara M, Williams P, Loris R, Nativi C, Rosenau F, Jaeger KE, Darbre T, Reymond JL. Inhibition and dispersion of Pseudomonas aeruginosa biofilms by glycopeptide dendrimers targeting the fucose‐specific lectin LecB. Chem Biol 2008, 15:1249–1257.</note><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>15</number></detail><extent unit="pages"><start>1249</start><end>1257.</end></extent></part><relatedItem type="host"><titleInfo><title>Chem Biol</title></titleInfo><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>15</number></detail><extent unit="pages"><start>1249</start><end>1257.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit113"><titleInfo><title>Glycopeptide dendrimers with high affinity for the fucose‐binding lectin LecB from Pseudomonas aeruginosa.</title></titleInfo><name type="personal"><namePart type="given">E</namePart><namePart type="family">Kolomiets</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MA</namePart><namePart type="family">Swiderska</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RU</namePart><namePart type="family">Kadam</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">EMV</namePart><namePart type="family">Johansson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">KE</namePart><namePart type="family">Jaeger</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T</namePart><namePart type="family">Darbre</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JL.</namePart><namePart type="family">Reymond</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Kolomiets E, Swiderska MA, Kadam RU, Johansson EMV, Jaeger KE, Darbre T, Reymond JL. Glycopeptide dendrimers with high affinity for the fucose‐binding lectin LecB from Pseudomonas aeruginosa. ChemMedChem 2009, 4:562–569.</note><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>4</number></detail><extent unit="pages"><start>562</start><end>569.</end></extent></part><relatedItem type="host"><titleInfo><title>ChemMedChem</title></titleInfo><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>4</number></detail><extent unit="pages"><start>562</start><end>569.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit114"><titleInfo><title>A glycopeptide dendrimer inhibitor of the galactose‐specific lectin LecA and of Pseudomonas aeruginosa biofilms.</title></titleInfo><name type="personal"><namePart type="given">RU</namePart><namePart type="family">Kadam</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Bergmann</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Hurley</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D</namePart><namePart type="family">Garg</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Cacciarini</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MA</namePart><namePart type="family">Swiderska</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C</namePart><namePart type="family">Nativi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Sattler</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AR</namePart><namePart type="family">Smyth</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">O</namePart><namePart type="family">Williams</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Cámara</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Stocker</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T</namePart><namePart type="family">Darbre</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JL.</namePart><namePart type="family">Reymond</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Kadam RU, Bergmann M, Hurley M, Garg D, Cacciarini M, Swiderska MA, Nativi C, Sattler M, Smyth AR, Williams O, Cámara M, Stocker A, Darbre T, Reymond JL. A glycopeptide dendrimer inhibitor of the galactose‐specific lectin LecA and of Pseudomonas aeruginosa biofilms. Angew Chem Int Ed Engl 2011, 50:10631–10635.</note><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>50</number></detail><extent unit="pages"><start>10631</start><end>10635.</end></extent></part><relatedItem type="host"><titleInfo><title>Angew Chem Int Ed Engl</title></titleInfo><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>50</number></detail><extent unit="pages"><start>10631</start><end>10635.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit115"><titleInfo><title>Amine and ammonium functionalization of chloromethylsilane‐ended dendrimers. Antimicrobial activity studie.</title></titleInfo><name type="personal"><namePart type="given">P</namePart><namePart type="family">Ortega</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JL</namePart><namePart type="family">Copa‐Patiño</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Muñoz‐Fernández</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Soliveri</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R</namePart><namePart type="family">Gomez</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">FJ.</namePart><namePart type="family">de la Mata</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Ortega P, Copa‐Patiño JL, Muñoz‐Fernández A, Soliveri J, Gomez R, de la Mata FJ. Amine and ammonium functionalization of chloromethylsilane‐ended dendrimers. Antimicrobial activity studie. Org Biomol Chem 2008, 6:3264–3269.</note><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>6</number></detail><extent unit="pages"><start>3264</start><end>3269.</end></extent></part><relatedItem type="host"><titleInfo><title>Org Biomol Chem</title></titleInfo><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>6</number></detail><extent unit="pages"><start>3264</start><end>3269.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit116"><titleInfo><title>Effective functionalization of multiwalled carbon nanotube with amphiphilic poly(propyleneimine) dendrimer carrying silver nanoparticles for better dispersability and antimicrobial activity.</title></titleInfo><name type="personal"><namePart type="given">E</namePart><namePart type="family">Murugan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G.</namePart><namePart type="family">Vimala</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Murugan E, Vimala G. Effective functionalization of multiwalled carbon nanotube with amphiphilic poly(propyleneimine) dendrimer carrying silver nanoparticles for better dispersability and antimicrobial activity. J Colloid Interface Sci 2011, 357:354–365.</note><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>357</number></detail><extent unit="pages"><start>354</start><end>365.</end></extent></part><relatedItem type="host"><titleInfo><title>J Colloid Interface Sci</title></titleInfo><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>357</number></detail><extent unit="pages"><start>354</start><end>365.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit117"><titleInfo><title>Inhibition of bacterial growth and intramniotic infection in a guinea pig model of chorioamnionitis using PAMAM dendrimers.</title></titleInfo><name type="personal"><namePart type="given">B</namePart><namePart type="family">Wang</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RS</namePart><namePart type="family">Navath</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AR</namePart><namePart type="family">Menjoge</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B</namePart><namePart type="family">Balakrishnan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R</namePart><namePart type="family">Bellair</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H</namePart><namePart type="family">Dai</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R</namePart><namePart type="family">Romero</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Kannan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RM.</namePart><namePart type="family">Kannan</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Wang B, Navath RS, Menjoge AR, Balakrishnan B, Bellair R, Dai H, Romero R, Kannan S, Kannan RM. Inhibition of bacterial growth and intramniotic infection in a guinea pig model of chorioamnionitis using PAMAM dendrimers. Int J Pharm 2010, 395:298–308.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>395</number></detail><extent unit="pages"><start>298</start><end>308.</end></extent></part><relatedItem type="host"><titleInfo><title>Int J Pharm</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>395</number></detail><extent unit="pages"><start>298</start><end>308.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit118"><titleInfo><title>Development of a guinea pig model of chorioamnionitis and fetal brain injury.</title></titleInfo><name type="personal"><namePart type="given">LA</namePart><namePart type="family">Patrick</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">LM</namePart><namePart type="family">Gaudet</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AE</namePart><namePart type="family">Farley</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JP</namePart><namePart type="family">Rosssiter</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">LL</namePart><namePart type="family">Tomalty</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">GN.</namePart><namePart type="family">Smith</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Patrick LA, Gaudet LM, Farley AE, Rosssiter JP, Tomalty LL, Smith GN. Development of a guinea pig model of chorioamnionitis and fetal brain injury. Am J Obstet Gynecol 2004, 191:1205–1211.</note><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>191</number></detail><extent unit="pages"><start>1205</start><end>1211.</end></extent></part><relatedItem type="host"><titleInfo><title>Am J Obstet Gynecol</title></titleInfo><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>191</number></detail><extent unit="pages"><start>1205</start><end>1211.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit119"><titleInfo><title>Traditional and emerging antifungal therapies.</title></titleInfo><name type="personal"><namePart type="given">TM</namePart><namePart type="family">Arnold</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E</namePart><namePart type="family">Dotson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">GA</namePart><namePart type="family">Sarosi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">CA.</namePart><namePart type="family">Hage</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Arnold TM, Dotson E, Sarosi GA, Hage CA. Traditional and emerging antifungal therapies. Proc Am Thorac Soc 2010, 7:222–228.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>7</number></detail><extent unit="pages"><start>222</start><end>228.</end></extent></part><relatedItem type="host"><titleInfo><title>Proc Am Thorac Soc</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>7</number></detail><extent unit="pages"><start>222</start><end>228.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit120"><titleInfo><title>Therapy of systemic fungal infections: a pharmacologic perspective.</title></titleInfo><name type="personal"><namePart type="given">V</namePart><namePart type="family">Wiebe</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Karriker</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Wiebe V, Karriker M. Therapy of systemic fungal infections: a pharmacologic perspective. Clin Tech Small Anim Pract 2005, 20:250–257.</note><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>20</number></detail><extent unit="pages"><start>250</start><end>257.</end></extent></part><relatedItem type="host"><titleInfo><title>Clin Tech Small Anim Pract</title></titleInfo><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>20</number></detail><extent unit="pages"><start>250</start><end>257.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit121"><titleInfo><title>Synthesis, characterization and antimicrobial activity of water soluble dendritic macromolecules.</title></titleInfo><name type="personal"><namePart type="given">M</namePart><namePart type="family">Tulu</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">NM</namePart><namePart type="family">Aghatabay</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">MSenel</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C</namePart><namePart type="family">Dizman</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T</namePart><namePart type="family">Parali</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B.</namePart><namePart type="family">Dulger</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Tulu M, Aghatabay NM, MSenel M, Dizman C, Parali T, Dulger B. Synthesis, characterization and antimicrobial activity of water soluble dendritic macromolecules. Eur J Med Chem 2009, 44:1093–1099.</note><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>44</number></detail><extent unit="pages"><start>1093</start><end>1099.</end></extent></part><relatedItem type="host"><titleInfo><title>Eur J Med Chem</title></titleInfo><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>44</number></detail><extent unit="pages"><start>1093</start><end>1099.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit122"><titleInfo><title>Novel dendrimeric lipopeptides with antifungal activity.</title></titleInfo><name type="personal"><namePart type="given">J</namePart><namePart type="family">Janiszewska</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Sowińska</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Rajnisz</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Solecka</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">I</namePart><namePart type="family">Łącka</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Milewski</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Z.</namePart><namePart type="family">Urbańczyk‐Lipkowska</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Janiszewska J, Sowińska A, Rajnisz A, Solecka J, Łącka I, Milewski S, Urbańczyk‐Lipkowska Z. Novel dendrimeric lipopeptides with antifungal activity. Bioorg Med Chem Lett 2012, 22:1388–1393.</note><part><date>2012</date><detail type="volume"><caption>vol.</caption><number>22</number></detail><extent unit="pages"><start>1388</start><end>1393.</end></extent></part><relatedItem type="host"><titleInfo><title>Bioorg Med Chem Lett</title></titleInfo><part><date>2012</date><detail type="volume"><caption>vol.</caption><number>22</number></detail><extent unit="pages"><start>1388</start><end>1393.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit123"><titleInfo><title>The cell wall: a carbohydrate armour for the fungal cell.</title></titleInfo><name type="personal"><namePart type="given">JP.</namePart><namePart type="family">Latgé</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Latgé JP. The cell wall: a carbohydrate armour for the fungal cell. Mol Microbiol 2007, 66:279–290.</note><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>66</number></detail><extent unit="pages"><start>279</start><end>290.</end></extent></part><relatedItem type="host"><titleInfo><title>Mol Microbiol</title></titleInfo><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>66</number></detail><extent unit="pages"><start>279</start><end>290.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit124"><titleInfo><title>PAMAM dendrimer‐azithromycin conjugate nanodevices for the treatment of Chlamydia trachomatis infections.</title></titleInfo><name type="personal"><namePart type="given">MK</namePart><namePart type="family">Mishra</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">K</namePart><namePart type="family">Kotta</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Hali</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Wykes</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">HC</namePart><namePart type="family">Gerard</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AP</namePart><namePart type="family">Hudson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JA</namePart><namePart type="family">Whittum‐Hudson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RM.</namePart><namePart type="family">Kannan</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Mishra MK, Kotta K, Hali M, Wykes S, Gerard HC, Hudson AP, Whittum‐Hudson JA, Kannan RM. PAMAM dendrimer‐azithromycin conjugate nanodevices for the treatment of Chlamydia trachomatis infections. Nanomed Nanotech Biol Med 2011, 7:935–944.</note><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>7</number></detail><extent unit="pages"><start>935</start><end>944.</end></extent></part><relatedItem type="host"><titleInfo><title>Nanomed Nanotech Biol Med</title></titleInfo><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>7</number></detail><extent unit="pages"><start>935</start><end>944.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit125"><titleInfo><title>Nanosized dendritic polyguanidilyated translocators for enhanced solubility, permeability, and delivery of gatifloxacin.</title></titleInfo><name type="personal"><namePart type="given">C</namePart><namePart type="family">Durairaj</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RS</namePart><namePart type="family">Kadam</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JW</namePart><namePart type="family">Chandler</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">SL</namePart><namePart type="family">Hutcherson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">UB.</namePart><namePart type="family">Kompella</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Durairaj C, Kadam RS, Chandler JW, Hutcherson SL, Kompella UB. Nanosized dendritic polyguanidilyated translocators for enhanced solubility, permeability, and delivery of gatifloxacin. Invest Ophthalmol Vis Sci 2010, 51:5804–5816.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>51</number></detail><extent unit="pages"><start>5804</start><end>5816.</end></extent></part><relatedItem type="host"><titleInfo><title>Invest Ophthalmol Vis Sci</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>51</number></detail><extent unit="pages"><start>5804</start><end>5816.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit126"><titleInfo><title>Hydrogel of ketoconazole and PAMAM dendrimers: formulation and antifungal activity.</title></titleInfo><name type="personal"><namePart type="given">K</namePart><namePart type="family">Winnicka</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Wroblewska</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P</namePart><namePart type="family">Wieczorek</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">PT</namePart><namePart type="family">Sacha</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E.</namePart><namePart type="family">Tryniszewska</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Winnicka K, Wroblewska M, Wieczorek P, Sacha PT, Tryniszewska E. Hydrogel of ketoconazole and PAMAM dendrimers: formulation and antifungal activity. Molecules 2012, 17:4612–4624.</note><part><date>2012</date><detail type="volume"><caption>vol.</caption><number>17</number></detail><extent unit="pages"><start>4612</start><end>4624.</end></extent></part><relatedItem type="host"><titleInfo><title>Molecules</title></titleInfo><part><date>2012</date><detail type="volume"><caption>vol.</caption><number>17</number></detail><extent unit="pages"><start>4612</start><end>4624.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit127"><titleInfo><title>Evaluation of polyamidoamine (PAMAM) dendrimers as drug carriers of anti‐bacterial drugs using sulfamethoxazole (SMZ) as a model drug.</title></titleInfo><name type="personal"><namePart type="given">M</namePart><namePart type="family">Ma</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Y</namePart><namePart type="family">Cheng</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Z</namePart><namePart type="family">Xu</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P</namePart><namePart type="family">Xu</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H</namePart><namePart type="family">Qu</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Y</namePart><namePart type="family">Fang</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T</namePart><namePart type="family">Xu</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">L.</namePart><namePart type="family">Wen</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Ma M, Cheng Y, Xu Z, Xu P, Qu H, Fang Y, Xu T, Wen L. Evaluation of polyamidoamine (PAMAM) dendrimers as drug carriers of anti‐bacterial drugs using sulfamethoxazole (SMZ) as a model drug. Eur Med Chem 2007, 42:93–98.</note><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>42</number></detail><extent unit="pages"><start>93</start><end>98.</end></extent></part><relatedItem type="host"><titleInfo><title>Eur Med Chem</title></titleInfo><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>42</number></detail><extent unit="pages"><start>93</start><end>98.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit128"><titleInfo><title>Poly(amidoamine) dendrimer‐mediated synthesis and stabilization of silver sulfonamide nanoparticles with increased antibacterial activity.</title></titleInfo><name type="personal"><namePart type="given">SJ</namePart><namePart type="family">Strydom</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">WE</namePart><namePart type="family">Rose</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">DP</namePart><namePart type="family">Otto</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">W</namePart><namePart type="family">Liebenberg</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MM.</namePart><namePart type="family">de Villiers</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Strydom SJ, Rose WE, Otto DP, Liebenberg W, de Villiers MM. Poly(amidoamine) dendrimer‐mediated synthesis and stabilization of silver sulfonamide nanoparticles with increased antibacterial activity. Nanomed Nanotech Biol Med 2012, doi:10.1016/j.nano.2012.03.006.</note><part><date>2012</date></part><relatedItem type="host"><titleInfo><title>Nanomed Nanotech Biol Med</title></titleInfo><part><date>2012</date></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit129"><titleInfo><title>Control of bacterial persister cells by Trp/Arg‐containing antimicrobial peptides.</title></titleInfo><name type="personal"><namePart type="given">X</namePart><namePart type="family">Chen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Zhang</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C</namePart><namePart type="family">Zhou</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">NR</namePart><namePart type="family">Kallenbach</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D.</namePart><namePart type="family">Ren</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Chen X, Zhang M, Zhou C, Kallenbach NR, Ren D. Control of bacterial persister cells by Trp/Arg‐containing antimicrobial peptides. Appl Environ Microbiol 2011, 77:4878–4885.</note><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>77</number></detail><extent unit="pages"><start>4878</start><end>4885.</end></extent></part><relatedItem type="host"><titleInfo><title>Appl Environ Microbiol</title></titleInfo><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>77</number></detail><extent unit="pages"><start>4878</start><end>4885.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit130"><titleInfo><title>Persistence: mechanisms for triggering and enhancing phenotypic variability.</title></titleInfo><name type="personal"><namePart type="given">NQ.</namePart><namePart type="family">Balaban</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Balaban NQ. Persistence: mechanisms for triggering and enhancing phenotypic variability. Curr Opin Genet Dev 2011, 21:768–775.</note><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><extent unit="pages"><start>768</start><end>775.</end></extent></part><relatedItem type="host"><titleInfo><title>Curr Opin Genet Dev</title></titleInfo><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><extent unit="pages"><start>768</start><end>775.</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit131"><titleInfo><title>Role of persister cells in chronic infections: clinical relevance and perspectives on anti‐persister therapies.</title></titleInfo><name type="personal"><namePart type="given">M</namePart><namePart type="family">Fauvart</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">VN</namePart><namePart type="family">De Groote</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.</namePart><namePart type="family">Michiels</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Fauvart M, De Groote VN, Michiels J. Role of persister cells in chronic infections: clinical relevance and perspectives on anti‐persister therapies. J Med Microbiol 2011, 60:699–709.</note><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>60</number></detail><extent unit="pages"><start>699</start><end>709.</end></extent></part><relatedItem type="host"><titleInfo><title>J Med Microbiol</title></titleInfo><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>60</number></detail><extent unit="pages"><start>699</start><end>709.</end></extent></part></relatedItem></relatedItem><identifier type="istex">9831976E5B4267DD17E6ED28BFECEFD141B6FED3</identifier><identifier type="ark">ark:/67375/WNG-GGNMRLN8-Z</identifier><identifier type="DOI">10.1002/wnan.1181</identifier><identifier type="ArticleID">WNAN1181</identifier><accessCondition type="use and reproduction" contentType="copyright">Copyright © 2012 Wiley Periodicals, Inc.</accessCondition><recordInfo><recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-L0C46X92-X">wiley</recordContentSource><recordOrigin>Converted from (version ) to MODS version 3.6.</recordOrigin><recordCreationDate encoding="w3cdtf">2019-11-16</recordCreationDate></recordInfo></mods><json:item><extension>json</extension><original>false</original><mimetype>application/json</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-GGNMRLN8-Z/record.json</uri></json:item></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001183 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 001183 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= H2N2V1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:9831976E5B4267DD17E6ED28BFECEFD141B6FED3
|texte= Dendrimers—revolutionary drugs for infectious diseases
}}
| This area was generated with Dilib version V0.6.33. |  |